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Methadone Maintenance Treatment (MMT) is the most common treatment for women 
dependent on opioids during pregnancy. A growing body of research suggests that infants and 
children prenatally exposed to methadone and other opioids are at an increased risk of 
behavioural and emotional adjustment difficulties. However, the extent to which children 
prenatally exposed to opioids meet diagnostic criteria for mental health disorders is not known. 
The current study aimed to compare the early psychiatric outcomes and parent-reported 
behavioural and emotional adjustment difficulties of methadone-exposed (ME) and non-
exposed comparison children at age 4.5 years old. The final aim was to examine the extent to 
which early-onset psychiatric disorders associated with prenatal opioid exposure might be 
explained by confounding infant, maternal and socio-familial factors.   
The behavioural and emotional adjustment of 87 children born to mothers maintained 
on methadone during pregnancy and 103 non-exposed comparison children was evaluated in a 
structured parent interview when the children were 4.5 years old. Caregivers initially 
completed the Strengths and Difficulties Questionnaire (SDQ) as a screening measure for child 
behavioural and emotional problems and were then interviewed using the Development and 
Well-Being Assessment (DAWBA). The DAWBA online scoring system was subsequently 
used to generate provisional psychiatric disorder diagnoses, which were reviewed alongside 
other data by a registered clinical psychologist to assign final clinical diagnoses according to 
DSM-IV criteria. Measures of infant, maternal and socio-familial risk factors were also 
available from two earlier time points: late pregnancy/birth and at age 18 months.  
Caregivers of ME children reported significantly higher levels of conduct problems (p 
< .0001), hyperactivity/inattention (p < .0001), emotional difficulties (p = .01), peer difficulties 
(p = .002), total difficulties (p < .0001), and significantly lower levels of prosocial behaviour 






years. Caregivers of ME children also reported a significantly higher impact associated with 
the child’s difficulties (p = .001). With the exception of emotional difficulties (p = .05), a 
significantly higher proportion of ME children had scores that fell within the clinical range for 
each of the other SDQ subscales. In terms of externalising disorder diagnoses, ME children 
had significantly higher rates of any diagnosis of Attention-Deficit Hyperactivity Disorder 
(ADHD)  (p = .001), Conduct Disorder  (CD) (p = .003) and Oppositional Defiant Disorder 
(ODD) (p < .0001). Overall, ME children were not significantly more likely to meet diagnostic 
criteria for an internalising disorder. Furthermore, ME children were significantly more likely 
to be diagnosed with comorbid psychiatric disorders (p < .0001). After controlling for 
confounding variables, group status remained a significant predictor for any diagnosis of 
ODD/CD at age 4.5 years (p = .02). In contrast, other psychiatric disorder outcomes at age 4.5 
years were largely explained by a range of confounding factors which included social risk, 
maternal psychopathology and poly-drug use.   
The findings of the current study suggest that children born to mothers maintained on 
methadone are at an increased risk of early-onset psychiatric disorder, the most common of 
which were ADHD, ODD and CD. The risk for externalising disorder was much greater than 
internalising disorders at age 4.5 years. Findings tend to suggest that a complex interplay of 
teratogenic, biological and environmental influences may be contributing to ME children’s 
mental health risk. This raises concerns about the future developmental trajectory of mental 
health difficulties in ME children and heightens the need for early intervention and ongoing 
social and clinical support. Future research is necessary to explore the relative contributions of 
postnatal risk factors that may potentially mediate the relationship between methadone 
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1.1  Methadone Maintenance Treatment 
1.1.1 Opioid Use and Abuse 
The use and abuse of opioids during pregnancy is a significant global public health 
issue. Maternal opioid use during pregnancy can pose a risk to the mother and her developing 
infant, which can, in turn, result in a cascade of adverse child neuroanatomical and 
developmental outcomes (Monnelly, Hamilton, Chappell, Mactier, & Boardman, 2018). 
Opioids are a class of drugs that are derived from the opium poppy plant Papaver 
Somniferum (Woodward, McPherson, & Volpe, 2018). The term “opioid” includes all 
substances that have morphine-like effects, including synthetic drugs such as methadone and 
natural opiates such as morphine (Ministry of Health, 2014). Previously, the most commonly 
used opioids were heroin and opium (Woodward et al., 2018). Now, synthetic opioids such as 
fentanyl, codeine and methadone are being increasingly used.  
For centuries, opioids have been used clinically and recreationally as they provide pain 
management as well as additional euphoric effects (Woodward et al., 2018). Due to the 
euphoria experienced when taking opioids, they can be misused. Chronic and recurrent misuse 
of opioids can lead to addiction. Opioid addiction is often chronic, treatment can be difficult, 
and is often associated with mortality (Kolodny et al., 2015). The use and abuse of opioids 
increased significantly in the 20th century.  
Heroin abuse in New York City escalated after World War II and deaths associated 
with intravenous heroin use surged from 7.2 per 10,000 deaths to 35.8 per 10,000 deaths 
between 1950 and 1961 (Joseph, Stancliff, & Langrod, 2000). The recent opioid epidemic, 






opioids, is having a significant impact within first-world countries and has generated a public 
health crisis (Shipton, 2018). For example, within the USA, just under 400,000 people died as 
a result of opioid overdose between 1999 and 2017 (Scholl, Seth, Kariisa, Wilson, & Baldwin, 
2018).  
A similar trend appears to be occurring in New Zealand. Between 2001 and 2012, 
deaths in New Zealand related to opioids had an increase of 33%, with deaths likely attributed 
to prescribed morphine, codeine and methadone (Shipton, Shipton, Williman, & Shipton, 
2017). Due to New Zealand’s geographic isolation and various other factors such as a small 
marketplace and effective law enforcement (McMinn, 2014; Shipton et al., 2017), heroin is not 
as easily attainable as prescription opioids. Opioid dependence in New Zealand often involves 
the use and misuse of pharmaceutical opioids, the opium poppy and home-bake heroin 
(Ministry of Health, 2014). However, the misuse of both opioid analgesics and illicit heroin 
remains a significant issue and can lead to lasting impairment.   
The use and abuse of opioids have direct effects on the brain and central nervous 
system. When an opioid travels through the bloodstream, it attaches to mu-opioid receptors 
(Kosten & George, 2002). Opioid receptors are located throughout different areas of the body, 
with the most pronounced effects on the central nervous system and gastrointestinal tract 
(Ministry of Health, 2014). When a person begins to take opioids, the mesolimbic reward 
system is activated and signals are created in the ventral tegmental area which then results in 
dopamine being released in the nucleus accumbens (Kosten & George, 2002). This process 
generates feelings of pleasure and other parts of the brain associate these feelings with the 
situations they occur in (Kosten & George, 2002). The person then develops conditioned 
associations and may experience cravings when encountering these situations/environments 
again (Kosten & George, 2002). When the person taking the opioid is not in significant pain 






repetitive recreational use of opioids can occur. When a person becomes tolerant to increasing 
levels of opioids and becomes dependent on them, they are likely to develop withdrawals when 
no longer using the drug. Experiencing opioid withdrawal symptoms is a significant contributor 
to dependence and addiction (Kosten & George, 2002).  
The chronic abuse of opioids can result in a diagnosis of Opioid Use Disorder (OUD). 
Opioid Use Disorder is characterised by a number of symptoms, including the inability to 
control opioid use, withdrawals, tolerance and intense cravings (American Psychiatric 
Association, 2013). Opioid Use Disorder symptoms reflect prolonged and compulsive use of 
opioid substances (American Psychiatric Association, 2013). Furthermore, opioid use during 
pregnancy can also pose a risk to the developing child and increase the need for social and 
medical services, which can impose economic burdens on society (Ross, Graham, Money, & 
Stanwood, 2015). Opioid Substitution Treatment, such as Methadone Maintenance Treatment 
(MMT), is the most widely used harm-reduction approach to treating individuals with OUD 
(Bawor et al., 2014).  
1.1.2 Methadone Maintenance Treatment for Opioid Dependence 
Methadone Maintenance Treatment was developed to help withdraw individuals from 
heroin. New Zealand was introduced to Opioid Substitution Treatment (OST) in the 1970s to 
manage opioid addiction and dependence (Deering, Sellman, & Adamson, 2014). 
Maintenance with methadone and buprenorphine, both opioids, are effective treatments used 
within OST in New Zealand. Methadone, a full mu-opioid agonist, is a synthetic opioid and 
is well known for its use as a treatment for opioid addiction. Buprenorphine is a semi-
synthetic partial agonist that is also used to treat opioid addiction. Methadone has a long half-
life of roughly 24 to 36 hours (Joseph et al., 2000), compared to heroin which has a relatively 
short half-life. The long half-life of methadone allows for administration once daily and can 






orally, either as a tablet or in liquid form (Bart, 2012). In addition to pharmaceutical 
treatment, MMT is often accompanied by psychosocial support. Methadone is only able to be 
legally administered in clinically observed and regulated environments, with restrictions on 
take-home doses (Wechsberg & Kasten, 2007). 
Methadone Maintenance Treatment helps to reduce illicit heroin use, death from 
overdose and infectious disease transmission, and can improve the health of the individual 
(Ward, Hall, & Mattick, 1999). This process involves substituting an illicit substance such as 
heroin with a stable, pure dose of methadone (Burns, Mattick, Lim, & Wallace, 2007). 
Objectives of MMT in New Zealand include assisting individuals to safely withdraw from 
opioids, reduce crime, mortality, morbidity, and drug misuse, and importantly, to help improve 
the health and social and personal functioning of individuals enrolled in MMT (Ministry of 
Health, 2001). Despite the evidence that methadone is effective and safe for the individual 
enrolled in MMT, it is important to understand the potential impact of opioid exposure in-utero 
on the developing child.  
1.1.3 Methadone Maintenance Treatment During Pregnancy 
Methadone Maintenance Treatment is considered to be the primary treatment of choice 
for pregnant women with opioid dependency (Jones, O’Grady, Malfi, & Tuten, 2008). The 
volume of data about the safety and efficacy of MMT during pregnancy and breastfeeding is 
greater than for buprenorphine maintenance (Ministry of Health, 2014). Although, 
buprenorphine is now also increasingly being used in the U.S.A, due to the suggestion that it 
may be associated with lower rates of Neonatal Abstinence Syndrome (Jansson et al., 2019).  
Pregnant women are a priority group for MMT in New Zealand (Ministry of Health, 
2001). These pregnancies are deemed high risk (Ministry of Health, 2014). Pregnancy in 
opioid-dependent women who have not received treatment is associated with increased infant 






been identified as a risk factor for preterm labour and delivery, placental abruption, intrauterine 
foetal death and growth retardation, blood-borne viruses, and pre-eclampsia (Ministry of 
Health, 2014). The most common outcome of opioid use during pregnancy is Neonatal 
Abstinence Syndrome (NAS) which can occur in neonates after prenatal drug exposure (Larson 
et al., 2019). Neonatal Abstinence Syndrome also occurs after prenatal exposure to methadone. 
Other factors associated with maternal opioid use which can have an adverse impact on the 
developing child include the effect of multiple substances and psychosocial factors such as 
stress, maternal psychopathology and lifestyle, and poverty (Hans & Jeremy, 2001). This 
suggests the negative impact of maternal drug use on the developmental trajectory of a child is 
likely multifactorial. MMT can help stabilise and minimise the effects that opioid exposure can 
have on the developing foetus (Woodward et al., 2018). MMT can also prevent relapse, 
improve adherence with obstetrical care and help reduce foetal exposure to other risky maternal 
behaviours and illicit drugs (Jones et al., 2008).  
Similar to opioids, methadone crosses the placenta and blood-brain barrier, exposing 
the developing foetus to exogenous opioids (Monnelly et al., 2018). In general, opioids act 
diffusely and can influence multiple neurotransmitter innervations and brain regions (Yanai et 
al., 2003). Pre-clinical studies have suggested that prenatal methadone exposure may alter 
myelination and the developing cholinergic, dopaminergic and serotonergic systems, resulting 
in a cascade of neuroanatomical changes (Monnelly et al., 2018). These early alterations in 
brain development may increase an infant’s risk of early behavioural dysregulation and longer-
term neurodevelopmental problems. 
1.2  Outcomes of Methadone Exposure on Infant and Child Neurodevelopment 
 
Although numerous short-term studies have been published on the developmental 






and emotional outcomes associated with prenatal methadone exposure in preschool and older 
children is scarce. Historically, existing research on the developmental outcomes of children 
exposed to opioids (including methadone) has focused on infant clinical, physical and cognitive 
outcomes. The following section provides a brief review of the findings on the effects of 
prenatal methadone exposure on infant neurodevelopment, with a more in-depth consideration 
of studies examining emotional and behavioural adjustment outcomes.  
1.2.1 Neonatal Outcomes 
Many studies have investigated infant clinical and physical outcomes such as head 
circumference, length, preterm birth and NAS, either at birth or shortly after delivery. Infants 
born to mothers maintained on methadone are at an elevated risk of being born preterm. When 
born close to term, methadone-exposed infants have been found to weigh less, have smaller 
head circumferences and are shorter in length than infants born to non-drug using mothers 
(Woodward et al., 2018).   
Although methadone has been found to minimise the adverse effects that opioid 
exposure can have on the developing foetus, methadone-exposed infants are at risk of being 
born with adverse neonatal outcomes. Studies have reported elevated rates of preterm birth in 
opioid-exposed infants (Cleary et al., 2011; Hunt, Tzioumi, Collins, & Jeffery, 2008), which 
has been defined as the birth of an infant <37 weeks’ gestation (Almario, Seligman, Dysart, 
Berghella, & Baxter, 2009; Cleary et al., 2011; Lim, Prasad, Samuels, Gardner, & Cordero, 
2009). There is a substantial amount of research on the weight, head circumference and body 
length of ME infants and young children. Approximately 10% to 35% of ME infants are of low 
birth weight (i.e., <2500 grams) (Woodward et al., 2018). Various studies have reported 
decreased birth weight in ME infants (Hans, 1989; Hulse, Milne, English, & Holman, 1997; 
Hunt et al., 2008). Symmetrically smaller head circumferences have also been found in infants 






(Kaltenbach & Finnegan, 1987; Rosen & Johnson, 1985). Multiple studies have investigated 
the average body length of methadone-exposed infants which have resulted in mixed findings. 
For example, Hans (1989) found that children aged two years who had been exposed to 
methadone in utero were shorter in height than the non-exposed comparison infants, however, 
the means for both groups were in the developmentally typical range. Studies have also 
reported significant differences in body length between methadone-exposed and non-exposed 
children that persisted throughout the preschool and childhood years (Hunt et al., 2008; 
Soepatmi, 1994) Although infants born to methadone-using mothers have been found to have 
disturbances in intrauterine growth, neonatal outcomes associated with untreated heroin use 
are considered to be more adverse than outcomes associated with methadone exposure 
(Woodward et al., 2018).  
Neonatal Abstinence Syndrome (NAS) is prevalent in infants who have been prenatally 
exposed to methadone, due to the sudden end of drug exposure after the infant is born. Neonatal 
Abstinence Syndrome is a drug withdrawal syndrome that develops due to maternal opioid use 
during pregnancy and results in symptoms such as poor sleep, a high-pitched cry, irritability 
and uncoordinated sucking reflexes (Committee on Obstetric Practice, 2017). Numerous 
factors can influence how NAS is expressed in an infant, including poor maternal nutrition, 
obstetric and medical care, the timing of opioid pregnancy exposure and maternal stress linked 
to Opioid Use Disorder (Jansson & Patrick, 2019). Rates of NAS among infants born to 
mothers maintained on methadone during pregnancy ranges from approximately 13% to 90% 
(Woodward et al., 2018). As reported by Azuine et al. (2019), the prevalence of NAS in a 
longitudinal study of the Boston Birth Cohort had an increase that ranged from 12.1 per 1000 
births in 2003 to 63.1 per 1000 births in 2012 (Azuine et al., 2019). The increase in NAS cases 






methadone-exposed infants are of increased vulnerability in-utero and during the neonatal 
period for various clinical outcomes.  
 
1.2.2 Cognitive Development 
A small number of studies have examined the short-term cognitive outcomes of infants 
who have been exposed to methadone in-utero, with longer-term follow-up studies being 
relatively scarce. Additionally, although a substantial amount of research has been published 
on general cognition, limited studies have assessed the risk of learning and executive 
functioning problems in methadone-exposed children (Woodward et al., 2018). Additionally, 
ME infants are reported to perform within normal ranges on general cognitive measures (de 
Cubas & Field, 1993). The most commonly reported measure of cognitive outcome in opioid-
exposed children are the Bayley Scales of Infant Development (BSID) (Hans, 1989, Hunt et 
al., 2008; Rosen & Johnson, 1985; van Baar, Soepatmi, Gunning, & Akkerhuis, 1994), which 
assesses cognitive, motor, behavioural, and more recently language development in infants and 
young children. Findings on the cognitive outcomes of opioid-exposure tend to be mixed. For 
example, some studies have reported significant group differences between opioid-exposed and 
comparison children in measures of Intelligence Quotient (IQ) (Davis & Templer, 1988; Hunt 
et al., 2008; Sundelin-Wahlsten & Sarman, 2013), whereas some studies have reported no 
significant differences (de Cubas & Field, 1993).  
Nelson et al. (2020) recently conducted a meta-analysis and systematic review of the 
cognitive development of young children who had been exposed to methadone or 
buprenorphine in-utero. Results revealed high heterogeneity between the studies, however, 
opioid exposure was significantly associated with lower cognitive test scores overall (Nelson 
et al., 2020). After statistically accounting for infant and maternal differences, notably prenatal 






cognitive test scores attenuated (Nelson et al., 2020). This suggests that a range of adverse 
socio-familial, maternal and infant factors may also contribute to lower cognitive test scores in 
opioid-exposed young children. However, further research is needed to investigate the long-
term cognitive outcomes of ME children past the infancy stage.  
1.3  Behavioural and Emotional Adjustment in Preschool Children 
In the current study, the term behavioural and emotional adjustment difficulties 
encompass general behavioural and emotional problems as well as clinically significant 
adjustment difficulties, such as externalising and internalising mental health disorders. Both 
externalising and internalising problems are commonly presented in preschool children. These 
terms describe two broad dimensions of emotional, behavioural and social difficulties 
(Achenbach, Ivanova, Rescorla, Turner, & Althoff, 2016). Psychiatric disorders are also 
clustered according to prominent externalising and internalising symptoms (American 
Psychiatric Association, 2013). The major focus of this thesis is the psychiatric outcomes of 
preschool children that are discussed below.  
Behavioural adjustment difficulties were the first key outcome of interest in the present 
study. Children with behavioural maladjustment may exhibit externalising behaviour 
difficulties that are often disruptive, aggressive and hyperactive (Hinshaw, 1987). Children can 
display oppositional behaviour, refuse to follow directions or requests from adults and are often 
stubborn (Wicks-Nelson & Israel, 2000). Issues with inattention, impulsivity and hyperactivity 
are also included within this construct. Within the current study, the term “behavioural 
adjustment difficulties” comprises these behaviours, as well as social functioning difficulties. 
Externalising behaviour problems can cause multiple disturbances for the child and their social 
environment and are often predictive of further behaviour problems and psychopathology 






externalising behaviours do not necessarily indicate or predict clinical problems (Wicks-
Nelson & Israel, 2000). Problematic behaviours during the preschool years can be transient 
and age-appropriate. Many children display defiant and rule-breaking behaviour during early 
childhood (Hann, 2001), which can be developmentally normative behaviour. Externalising 
behaviours can reflect frustration and conflict relative to the child’s young age (Campbell, 
1995). Additionally, it can be difficult to determine the boundaries that separate abnormal and 
typical impulsivity, inattention and hyperactivity in preschool-age children.  
Emotional maladjustment in preschool children was the additional key outcome of 
interest in the current study. Emotional adjustment difficulties are often characterised by 
internalising symptoms such as feelings of depression, anxiety and withdrawal. It is not 
uncommon for young children to have general fears and anxieties (Tandon, Cardeli, & Luby, 
2009). During early childhood, anxiety is more prevalent than depression (Shapiro, 2019). 
When anxiety patterns are distressing, impairing, pervasive and uncontrollable, symptoms may 
reflect psychopathology (Tandon et al., 2009). Similarly, sadness, tearfulness and irritability in 
early childhood can indicate developmentally normative behaviours and emotions (Bufferd, 
Dougherty, & Olino, 2017). However, preschool children exhibiting behaviours such as 
decreased interest, pleasure and self-worth is less normative (Bufferd et al., 2017).  
 
1.3.1  Externalising Disorders 
Attention-Deficit Hyperactivity Disorder. Attention-Deficit Hyperactivity Disorder 
(ADHD) is a common neurodevelopmental disorder that often occurs during childhood and 
adolescence. It has been suggested that ADHD is a developmental impairment of executive 
functioning (Brown, 2002). Executive functioning underlies the ability to self-regulate, with 
self-regulation deficits being a central aspect of ADHD (Barkley, 2014). Across cultures, the 






Association, 2013). According to DSM-IV diagnostic criteria, ADHD subtypes are 
distinguished based on two symptom dimensions; inattention and hyperactivity/impulsivity 
(Lahey et al., 1998). Symptoms of ADHD should be inconsistent with the child’s level of 
development and must continue for at least six months (Buttross, 2007). Children with ADHD 
must also exhibit significant impairment in functioning, symptoms should cause impairment in 
more than one setting and have an age of onset before age seven (American Psychiatric 
Association, 2000).  
The three subtypes of ADHD include predominantly Inattentive type, predominantly 
Hyperactive-Impulsive type and Combined type. Inattention is characterised by being easily 
distracted, decreased task persistence, difficulties with sustaining attention and disorganisation 
(Lahey et al., 1998). Hyperactivity/impulsivity is characterised by issues related to the 
regulation of motor activity and impulsive responses (Lahey et al., 1998). Hyperactivity and 
impulsivity are often more likely to be visibly identified due to the disturbance that can be 
caused by these behaviours (Buttross, 2007). Finally, ADHD Combined type incorporates 
maladaptive levels of both inattentiveness and hyperactivity/impulsivity (Lahey et al., 1998). 
Within this study, the term ADHD refers to all subtypes. Attention-Deficit Hyperactivity 
Disorder symptoms are often able to be distinguished from normative behaviours before the 
child turns four (American Psychiatric Association, 2013).  In preschool-age children, the most 
common manifestation of ADHD is hyperactivity (American Psychiatric Association, 2013). 
This may be because children are not expected to pay attention for long periods in preschool, 
so inattentiveness may not be as observable during the preschool years compared to primary 
and secondary school environments. Children with ADHD can have difficulties with peer 
relationships and educational achievement and are at an elevated risk of developing Conduct 
Disorder and Antisocial Personality Disorder later in life compared to children without ADHD 






Oppositional Defiant Disorder. Oppositional Defiant Disorder (ODD) is defined as a 
recurrent and persistent pattern of hostile, defiant and negativistic behaviour, which leads to 
significant impairment in functioning and lasts at least six months (American Psychiatric 
Association, 2000). Children with ODD can exhibit anger and vindictiveness, with a majority 
of the behaviours being directed at the external environment, such as adults and authority 
figures (Steiner & Remsing, 2007). Keenan et al. (2011) examined oppositional defiant 
symptoms in a clinical sample of preschoolers and reported that the most common endorsed 
symptoms were defiance, loss of temper, deliberately annoying others and blaming others for 
their own mistakes. Although behavioural deviance is common in both ODD and ADHD, the 
argumentative and irritability that can be seen in ODD differs from the core symptoms that are 
observed in children with ADHD (Ghosh, Ray, & Basu, 2017). For an ODD diagnosis, 
symptoms must exceed developmentally normative behaviours according to the child’s age, 
culture and gender (American Psychiatric Association, 2013).  
Oppositional Defiant Disorder is less severe than other disruptive behaviour disorders 
such as Conduct Disorder and is often identified at an earlier stage of the child’s development 
(Tolan & Leventhal, 2013). Specifically, ODD often emerges at the end of preschool/early 
school-age (Steiner & Remsing, 2007). The prevalence rates for ODD can vary depending on 
gender and age, but the average estimate is around 3.3% (American Psychiatric Association, 
2013). Boylan, Vaillancourt, Boyle, and Szatmari (2007) systematically reviewed the 
prevalence rates of ODD in community samples of children and reported a range of  2.6% to 
15.6%, with the preschool prevalence rate ranging from 9% to 12%. During childhood, ODD 
is slightly more common in males than females (American Psychiatric Association, 2013). It 
can precede the development of CD, severely delinquent behaviour, and substance abuse in 






anger seen in ODD can predispose children to the risk of developing an emotional disorder 
(American Psychiatric Association, 2013).  
Conduct Disorder. Conduct Disorder (CD) is characterised by a persistent pattern of 
the violation of the rights of others or violation of major rules or norms (American Psychiatric 
Association, 2000; Keenan & Wakschlag, 2002). There are four major symptom categories of 
CD, which include aggression towards people and animals, property destruction, deceitfulness 
or theft, and serious rule violation (American Psychiatric Association, 2000). The individual 
must also be under 18 years of age for a diagnosis of CD (American Psychiatric Association, 
2000; Frick, 2016). These symptoms must also cause notable impairment in the individual’s 
functioning. Prevalence rates for CD range between 2% to >10% across cultures (American 
Psychiatric Association, 2013). Conduct Disorder can have an adolescent-onset or a childhood-
onset before age ten, with significant differences between these two developmental trajectories 
(Frick, 2016). Childhood-onset CD is often characterised by the early emergence of mild 
conduct problems during preschool or elementary which then tend to persist and increase in 
severity (Frick & Nigg, 2012). Children with childhood-onset CD often display aggression, are 
more likely to be male and have poor peer relationships (American Psychiatric Association, 
2013). Typically, CD is first identified in middle childhood or during adolescence (Tolan & 
Leventhal, 2013). However, conduct problems which originate during the preschool years often 
extend over the life course and can have significant consequences for further development 
(Fergusson, Boden, & Hayne, 2011). Conduct problems in childhood and adolescence can lead 
to adverse outcomes such as crime, suicidal behaviour, mental illness, antisocial behaviour,  








1.3.2  Internalising Disorders 
  
In contrast to externalising disorders, internalising disorders are characterised by 
anxiety, depressed mood, and related cognitive and physiological symptoms (American 
Psychiatric Association, 2013). The emergence of internalising disorders during the preschool 
years is a considerably under-researched area, compared to research surrounding externalising 
disorders during these years. Internalising disorders during childhood include depressive 
disorders such as Major Depressive Disorder and Disruptive Mood Dysregulation Disorder, as 
well as anxiety disorders such as Generalised Anxiety Disorder, Separation Anxiety Disorder, 
Specific Phobia, and Selective Mutism (American Psychiatric Association, 2013). There has 
been debate surrounding whether preschool-aged children can present with clinical depression, 
with some theorists positing that it is not developmentally possible. However, the 
understanding of depressive disorders in early childhood has progressed and the presence of 
these disorders in young children has been identified (Luby, 2010). Young children with 
depression can often present with somatic symptoms including stomach aches, issues with 
appetite, headaches and sleep difficulties (Shapiro, 2019). Instead of presenting as sad, young 
children can exhibit irritability (Shapiro, 2019). In comparison to externalising behaviour 
disorders, internalising disorders are less commonly presented in preschool-aged children.   
1.3.3  Comorbidity 
An important issue with respect to early-onset emotional and behavioural problems 
concerns not just the extent of individual problems, but also that of comorbidity, which is 
defined as the two or more psychiatric disorders occurring simultaneously. However, amongst 
the literature, little research has been done on the comorbidity of psychiatric disorders in the 
preschool years in comparison to childhood and adolescence. Comorbidity appears to be a 






Specifically, ADHD is highly comorbid with ODD, CD, and depressive and anxiety disorders 
(Cormier, 2008). The co-occurrence of ADHD and ODD has been consistently established in 
both clinic and community settings (Gadow & Nolan, 2002; Lavigne, LeBailly, Hopkins, 
Gouze, & Binns, 2009). Oppositional Defiant Disorder co-occurs with approximately one-half 
of children who meet criteria for ADHD Combined and one-quarter of children who meet 
criteria for ADHD Inattentive type (American Psychiatric Association, 2013). Approximately 
one quarter of children or adolescents with ADHD Combined have co-occurring CD (American 
Psychiatric Association, 2013). Boylan et al. (2007) reported the early onset of comorbidity 
between ODD and internalising disorders during the preschool years, with 10-20% of children 
with ODD diagnosed with a comorbid internalising disorder (Boylan et al., 2007). Within both 
the externalising and internalising groups, the sharing of environmental and genetic risk factors 
can potentially explain some of the comorbidities seen in both community and clinical samples 
(American Psychiatric Association, 2013). The combination of risk factors may result in the 
manifestation of both internalising and externalising behaviours (Boylan et al., 2007).  
 1.4 Literature Review 
 
The behavioural and emotional adjustment of preschool children who have been 
prenatally exposed to methadone is under-researched. Although, despite the scarcity of 
longitudinal research, emerging literature has revealed significant associations between opioid 
exposure in-utero and behavioural and emotional difficulties. A majority of the following 
studies have almost exclusively relied on widely used caregiver-report measures of behavioural 
and emotional difficulties such as the Child Behavior Checklist (CBCL) (de Cubas & Field, 
1993; Konijnenberg, Lund, & Melinder, 2015; Konijnenberg & Melinder, 2015; Nygaard, 
Slinning, Moe, & Walhovd, 2016; Ornoy, Segal, Bar-Hamburger, & Greenbaum, 2001; 






Additionally, some studies used caregiver-report measures to assess inattentiveness, 
hyperactivity and impulsivity (Nygaard et al., 2016; Sandtorv, Fevang, Nilsen, Bøe, Gjestad, 
Haugland, & Elgen, 2018; Sundelin-Wahlsten & Sarman, 2013), such as the parent- and 
teacher-report ADHD Rating Scale (ADHD-RS) and the Swanson, Nolan, and Pelham 
Questionnaire, Revision IV (SNAP-IV).  
An important study within the literature is a retrospective medical review by Azuine et 
al. (2019), which is the only study to date which has examined the association between prenatal 
opioid exposure and psychiatric diagnostic outcome. Rather than relying on parental reports of 
child adjustment difficulties, this study investigated the rates of psychiatric diagnoses in 
children by reviewing medical records. However, this study likely underestimates the true 
prevalence of psychiatric difficulties in opioid-exposed children. This is because the sample is 
confined to the children who came into contact with clinical services and received a formal 
diagnosis. In contrast, the current study is based on a community sample of women and their 
children. Although they can be expensive, community samples are ideal as they are more 
representative of the general population (Egger & Angold, 2006). The study by Azuine et al. 
(2019) is reviewed further below.  
Studies were primarily accessed through the University of Canterbury library resources 
and conducted using a key word search on major psychiatry/psychology and medical search 
engines such as PubMed and PsycINFO. The references list of relevant, previously reviewed 
studies were also used as a supplementary guide. Due to the lack of research on the effects of 
methadone exposure specifically, this review will also include findings on children who have 
been exposed to other opioids such as heroin and buprenorphine. Eighteen studies were initially 
reviewed, which included observational measures of child behaviour. However, five studies 
were dropped from the final review due to the current focus on diagnostic and parent-report 






to the focus on teacher-reported internalising and externalising difficulties. This review 
includes both longitudinal and cross-sectional studies (n = 12) with an age range of 
approximately preschool to middle childhood.   
1.4.1  Studies Based on Parent Report  
The following studies included in this section, organised by year of publication, 
review the extent of parent/caregiver reported emotional and behavioural adjustment in 
children prenatally exposed to opioids.  
Wilson, McCreary, Kean, and Baxter (1979) conducted a cross-sectional study on the 
development of preschool children aged approximately 3-6 years who had been exposed to 
heroin in-utero. This study contained four groups; a heroin-exposed group (n = 22), a non-
exposed drug-environment comparison group selected through methadone maintenance 
programmes (n = 20), a non-exposed high medical risk comparison group selected from 
hospital records (n = 15) and a non-exposed matched socioeconomic comparison group 
selected from local school readiness programmes (n = 20). Drug use data were obtained from 
medical records and the use of multiple drugs was noted in the target group of women who 
predominantly used heroin during pregnancy. Race, sex, age, SES and time spent in a school 
readiness programme were adjusted for in the analysis. As rated by parents on the Child 
Behavior Rating Scales, the heroin-exposed group experienced difficulties in both self and 
social adjustment (p < .01). Specifically, items that resulted in significant differences between 
the heroin-exposed group and comparison groups included aggression, impulsiveness, peer 
difficulties and temper. Although this study is dated, the use of multiple comparison groups to 
distinguish between environmental and teratogenic effects gives a clearer indication of the 
relationship between opioid exposure and behavioural outcome and the influence of socio-
familial and perinatal variables. Later studies also employed this method of investigating 






de Cubas and Field (1993) conducted a cross-sectional study on the developmental 
outcomes of children exposed to methadone in-utero. A methadone-exposed group of children 
(n = 20) were selected from mothers participating in MMT during pregnancy/after birth. A 
majority of children from this group were Caucasian (17/20), which limits the generalisability 
of the findings. A non-exposed control group (n = 20) were selected from children seen in a 
local developmental evaluation clinic and were matched on demographic variables such as 
SES, ethnicity, maternal education, family structure, age/school grade level, sex, perinatal 
complications and alcohol and nicotine use. There were no statistically significant differences 
between both groups on these variables. Both groups had a wide age range of 6-13 years (M= 
8.5 years & M= 7.8 years, respectively). Behaviour problems were measured on the maternal-
report CBCL. The two groups differed on virtually all CBCL scales. In particular, methadone-
exposed children scored higher on measures of hyperactivity (p ≤  .001) social withdrawal (p 
< .05), depression (p ≤ .001), somatic complaints (p ≤ .01), aggression (p ≤ .01), delinquency 
(p ≤ .001), and internalising (p ≤  .001) and externalising (p ≤  .001) problem scales. This 
suggests that methadone-exposed children at school-age present with various externalising and 
internalising difficulties that are significantly higher than non-exposed children at school-age.  
Soepatmi (1994) assessed behaviour problems in children prenatally exposed to either 
1) heroin or 2) heroin and methadone (n = 91) between 4-12 years old in a case-control 
longitudinal study. Opioid-exposed children were enrolled in the infants of drug-dependent 
mothers study (IDDM) and were referred for long-term follow-up. No control group was 
included in this study; results were referenced to large-scale Dutch studies. Only 67/157 (43%) 
children were able to be followed up for more than a year. Behaviour problems were assessed 
using the CBCL, which resulted in a significantly larger proportion of children exposed to 
opioids obtaining a total behaviour problem score >90, compared to the reference group. 






.01). This suggests the presence of age and gender-specific effects. Social competence was also 
assessed on the CBCL. Mirroring the previous findings, the number of children who obtained 
a total competence score ≤10 was significantly higher in opioid-exposed boys aged 4-5 years 
(p = .011) and opioid-exposed girls aged 6-11 years (p = .009) compared to comparison 
children. However, this study was limited by the lack of consideration of confounding variables 
and no control group. Additionally, this study did not report further numeral information about 
results. 
van Baar, Soepatmi, Gunning, and Akkerhuis (1994) conducted a prospective 
longitudinal study on children from birth to 5.5 years old who had been prenatally exposed to 
heroin, methadone and cocaine. Thirty-five infants of drug-dependent women were initially 
enrolled in the study after birth, who were also a part of the IDDM study included in Soepatmi’s 
(1994) research. Almost all women who were addicted to drugs had been using combinations 
of multiple substances during pregnancy (94%), determined by urine toxicology analyses and 
maternal interviews. One-third of women were participating in MMT during their third 
trimester. Reference children (n = 35) were not exposed to substances in-utero and were also 
enrolled shortly after birth. At 4.5 years, the exposed children were reported to have more 
behavioural problems, depressive symptoms, and difficulties with interactions with peers and 
adults, and increased aggressive behaviour on the caregiver-report CBCL. However, at 5.5 
years of age, behaviour problems were not present. This study did not describe the behavioural 
difficulties in opioid-exposed children further.  
Ornoy, Segal, Bar-Hamburger, and Greenbaum (2001) investigated externalising 
behaviour difficulties in children aged 5-12 years born to heroin-dependent mothers in a case-
control, cross-sectional study. Children were divided into five groups to explore the effects of 
environment and prenatal teratogen exposure. The first group of children were born to drug-






to drug-dependent mothers but were adopted (n = 34) and the third group were born to heroin-
dependent fathers and were raised by their biological parents (n = 33). All parents who used 
heroin also used a variety of psychoactive drugs. The fourth group comprised non-drug-
addicted parents but low SES (n = 32) who were referred to the social services institute, and 
the fifth group served as control participants recruited from mainstream schools (n = 30). 
Caregiver-report behaviour measures included the CBCL and Conners Questionnaire with 
Deutch’s modification for attention deficit. Approximately one-half of children born to mothers 
dependent on heroin and raised at home met the clinical cut-off point for ADHD (>21), which 
was significantly higher than control children (p < .01) and the remaining groups (p < .05). 
Approximately one quarter of adopted children and children born to heroin-dependent fathers 
met the clinical cut-off (p < .01) and 21% of children with environmental deprivation (p <  .01) 
met the clinical cut-off point compared to no control children. All groups had significantly 
higher scores on the CBCL compared to control children. Externalising behaviour scores were 
highest in children who had been born to heroin-dependent mothers who were raised at home, 
with these children scoring significantly higher on the CBCL externalising behaviour subscale 
in comparison to all groups except for children born to heroin-dependent fathers. Heroin- 
exposed children also had significantly higher internalising difficulties than control children (p 
< .01). These results suggest elevated levels of externalising behaviour problems in opioid-
exposed children may be due to an interaction of heroin exposure and environmental 
conditions. 
Hunt et al. (2008) investigated the social maturity of children at 18 months and 3 years 
who had been exposed to methadone in-utero in a case-control, longitudinal study. Data on the 
methadone-exposed children (n = 133) were gathered from mothers who were being prescribed 
methadone during pregnancy and were compliant with their treatment. During their course of 






substances as well as regular clinic visits. Exclusion criteria included the presence of NAS 
without enrolment in a methadone maintenance programme or taking other substances of 
abuse. The non-exposed comparison group of children (n = 103) were recruited from antenatal 
clinics. Mothers were matched on factors such as ethnic background, age, previous obstetric 
history and height. Assessments were not completed blindly, as the assessments were 
conducted at the children’s home. Only 50% of children were retained at the time of the three-
year assessment. Primary caregiver-reported social maturity was measured using the Vineland 
Social Maturity Scale. Results revealed a significant difference between the methadone-
exposed and non-exposed comparison children in social maturity, with the exposed children 
scoring significantly lower at both 18 months and three years (p < .05). This suggests that 
methadone-exposed children may exhibit lower levels of social competence than non-exposed 
children. 
Sundelin-Wahlsten and Sarman (2013) investigated behavioural and emotional 
adjustment in children aged 5-6 years’ old who were prenatally exposed to buprenorphine (n = 
25) in a cross-sectional study. Initially, the mothers of 45 buprenorphine-exposed children were 
approached to participate and 28 accepted participation, but the number dropped to 25 due to 
unfinished tests. Instead of a control group, exposed children’s results were compared to results 
from other studies. Mothers were enrolled in an opioid maintenance treatment programme at 
the time of pregnancy, with a mean buprenorphine daily dose of 15.1mg. Overall, 78% of 
women smoked during pregnancy, which was not described further. Outcome measures 
included the parent and teacher-report BROWN ADD Scales and SDQ. However, nine teachers 
did not return the BROWN and SDQ tests. Maternal self-report of exposed children’s ADHD 
symptoms resulted in significantly higher scores on the BROWN ADD Scales compared to 
children without ADHD, but lower compared to children with ADHD. Comparatively, teacher-






ADHD.  There were no significant parent-reported problems on the SDQ. However, teachers 
reported elevated hyperactivity/attention (6.7 ± 2.7) and problem scores (≤ 7.0 ± 2.5). Taken 
together, teachers were more likely to report externalising behaviour difficulties compared to 
parents. This could suggest potential parental under-reporting or context-specific effects, as 
children’s hyperactivity and inattention may be more clearly observed in the classroom. This 
study did not control for potential confounders, therefore, the conclusions drawn must be taken 
with precaution. The rate of non-completed psychometric tests is also of concern, as the 
children who were unable to be assessed could have had markedly different environmental 
characteristics to those who had available data. Additionally, significant differences were 
found in activity, attention, and memory between the children who did not have returned 
teacher reports and the remaining 16 children.  
Konijnenberg et al. (2015) investigated the behavioural outcomes of preschool children 
who had been exposed to methadone (n = 24) or buprenorphine (n = 11) in-utero in a 
prospective cohort study. There was no non-exposed comparison group of children. Mothers 
were recruited from opioid maintenance treatment centres throughout Norway and self-
reported the concurrent use of a range of licit and illicit substances such as tobacco, alcohol, 
amphetamines and marijuana during pregnancy. The authors controlled for child age, birth 
weight, and maternal employment and education in their analyses. Behavioural outcomes were 
measured using the caregiver-report CBCL. The mean CBCL scores fell within the normal 
range for both groups of children. This study found support for the maternal risk model as well 
as the combined model, but not the teratogenic model. Although there were no elevated 
behaviour difficulties in opioid-exposed children, results suggest that the behavioural outcomes 
could be a result of the combination of maternal/environmental factors in addition to opioid 
exposure, rather than solely opioid exposure. Another study on the same cohort of children as 






children (Konijnenberg & Melinder, 2015). This study included a methadone/buprenorphine 
exposed group (n = 31)  and a comparison group (n = 25). Attention problems were measured 
using the ‘Attention Problems’ subscale of the CBCL. After adjusting for the same confounders 
in the previous study by Konijnenberg et al. (2015), there were no significant group effects for 
attention difficulties according to parent report. These results mirror the previous CBCL 
findings reported by Konijnenberg et al. (2015), suggesting that methadone and buprenorphine-
exposed children are not at an increased risk of caregiver-reported behavioural issues.  
Nygaard et al. (2016) conducted a prospective, longitudinal study on the attention and 
behaviour problems of children who had been prenatally exposed to opiates and multiple other 
substances. The drug-exposed group (n = 72), recruited from an in-patient clinic, and the non-
exposed comparison group (n = 58), recruited from local health centres, were followed up at 
ages 4 ½ years old and 8 ½ years old. Twenty-six participants were lost at the 8 ½ year follow-
up, with 79% of exposed children and 81% of non-exposed children retained. The use of 
multiple substances during pregnancy such as tobacco (n = 72), opiates (n = 39), alcohol (n = 
9), and benzodiazepines (n = 8) were reported via maternal self-report or from medical staff 
report and records. This study adjusted for parental SES, birth weight, gestational age, and time 
of assessment. Inattention, hyperactivity and impulsivity were assessed using the parent and 
teacher-report ADHD Rating Scale. According to caregiver report, 25% (n = 14) children who 
were exposed to opiates and other substances during pregnancy had scores that indicated 
ADHD problems, and according to teacher report, 17% (n = 9) of the exposed children had 
scores that indicated ADHD problems. No comparison children obtained scores above the cut-
off point for both parent and teacher report. Nygaard et al. (2016) also compared drug-exposed 
children to comparison children at 8 ½ on the CBCL and Teachers Report Form (TRF). There 
were significant group differences in caregiver-reported externalising (p = .05), attention (p =  






that were ≥ 95th percentile on the CBCL total problem scale, compared to one comparison child. 
Teachers also reported significantly higher levels of externalising and attention difficulties in 
the exposed group. Parents also reported an increase in externalising and internalising 
difficulties over time. Unlike many other studies, this study included the use of both parental 
and teacher reports which was useful for examining behaviour across different settings. 
Rates of inattention, hyperactivity and impulsivity in children exposed prenatally to 
opiates and other illicit drugs were investigated by Sandtorv et al. (2018) in a cross-sectional 
study. The exposed group (n = 57) were a hospital-based group of children who had a medical 
history of prenatal drug exposure and had symptoms of developmental impairment. Of the 128 
children referred, 57 children had the relevant measures completed. Information about drug 
exposure during pregnancy was gathered from medical records and maternal self-report. The 
comparison group (n = 171) included children who had not been prenatally exposed to drugs 
and were participants in a population-based, longitudinal study. The reference group were 
matched on age and sex. Both groups of children were aged approximately ten years old at the 
time of assessment. Inattention, hyperactivity and impulsivity were measured on the Swanson, 
Nolan, and Pelham Questionnaire, Revision IV (SNAP-IV). Caregivers reported a significantly 
higher number of symptoms of ADHD Combined (M= 19.65 vs M= 4.13; p < .001), inattention 
(M = 10.79 vs M = 2.72; p < .001) and hyperactivity/impulsivity (M = 8.86 vs M = 1.42; p < 
.001) compared to the reference group, suggesting opiate-exposed children are at risk of 
presenting with increased levels of symptoms for all ADHD subtypes. An important limitation 
in this study is the limited consideration of the effects of poly drug use, as authors could not 
determine the use of alcohol or tobacco during pregnancy.  
Overall, the majority of the above studies suggest that opioid-exposed children are at 
an increased risk of both externalising and internalising difficulties. In particular, opioid-






inattentiveness, hyperactivity, impulsivity, and/or aggression (de Cubas & Field, 1993; 
Nygaard et al., 2016; Ornoy et al., 2001; Sandtorv et al., 2018; Soepatmi, 1994; Wilson et al., 
1979). Studies also reported increased levels of internalising (de Cubas & Field, 1993; Ornoy 
et al., 2001) and social difficulties (de Cubas & Field, 1993; Hunt et al., 2008; Nygaard et al., 
2016; Wilson et al., 1979) compared to comparison children. However, some studies did not 
report elevated behavioural and emotional adjustment difficulties in opioid-exposed children 
on parent-report measures (Konijnenberg et al., 2015; Konijnenberg & Melinder, 2015; 
Sundelin-Wahlsten & Sarman, 2013; van Baar et al., 1994). Table 1 presents a summary of the 
above studies and specific methodological limitations. Amongst the previous research, there is 
a lack of studies examining psychiatric outcome in opioid-exposed children. A recent study on 
the association between opioid exposure and child mental health outcome is reviewed below.  
1.4.2  Mental Health Outcome Studies 
To date, the longitudinal study by Azuine et al (2019) is the only study that has 
examined associations between prenatal opioid exposure and children’s later risk of a 
psychiatric diagnosis. Based on the Boston Birth Cohort, this sample consisted of 8509 mother-
newborn pairs enrolled at birth. A subset of these children had prenatal opioid exposure (n = 
454), based on a clinical diagnosis of NAS or maternal self-report of opioid use during 
pregnancy. Mothers with opioid exposure also self-reported the use of a range of substances 
during pregnancy such as marijuana, cocaine, stimulants, and crack. A large sample of mother-
child dyads (n = 3153) were enrolled in a postnatal follow-up and were followed from birth to 
21 years old. Psychiatric outcome (ADHD and CD/Emotional Disturbance) was assessed by 
review of ICD-9-CM and ICD-10 codes from children’s electronic medical records and was 
examined by child age groups (<6 years vs ≥6 years). Self-reported maternal educational level, 
marital status, household income, maternal age, and ethnicity were adjusted for, as well as low 






of life (n = 3106), children prenatally exposed to opioids had higher levels of Conduct 
Disorder/Emotional Disturbance diagnoses compared to non-exposed children, with a non-
adjusted OR of 2.17 (95% CI, 1.35-3.49) and an adjusted OR of 2.13 (95% CI, 1.20-3.77). In 
contrast, for children with records after age six (n = 2391), children who were prenatally 
exposed to opioids had higher levels of diagnoses of ADHD compared to non-exposed 
children, with a non-adjusted OR of 2.86 (95% CI, 1.67-4.91) and an adjusted OR of 2.55 (95% 
CI, 1.42-4.57). This study mainly consisted of a minority, low-income sample, hindering the 
generalisability of the findings. Nonetheless, these findings are an important and informative 








Studies on Parent-Reported and Diagnostic Measures of Behavioural, Emotional and Social Adjustment Outcomes of Children Prenatally 
Exposed to Opioids  
Study Research design 
Developmental 















Key Findings Limitations 
 





















group: n = 15 
4) SES 
comparison 






























race, sex, SES, 
age, and amount 

















(p < .05), 
physical 
adjustment (p < 
.05) and social-














use in analysis 
•Could not 
verify drug use  













group: n = 20 
 
 
1) Mean: 8.5 
years (range: 
6-13) 
2) Mean: 7.8 
years (range: 
6-13) 
















use of nicotine 




The two groups 
differed on 
virtually all  
CBCL scales 
(including 
internalising (p ≤ 
.001) 
 and externalising 
(p ≤ .001) 
problem scales), 
with ME children 
scoring in the 
less desirable 
direction 





















Study Research design 
Developmental 































































larger for boys 
aged 4-5 years (p 
< .001) and girls 
aged 6-11 (p = 
.012) exposed to 
opioids. 
The proportion of 
children with a 
total competence 
score ≤10  was 
significantly 
larger for boys 
aged 4-5 years (p 
= .011) and girls 
aged 6-11 years 
























of other drug 
use 
 










n = 35 
2) Comparison 
children: n = 35 
 
4 ½ years & 





the time of 
























problems in the 
opioid-exposed 
group at age 4.5 
years but no 
behavioural 


















Study Research design 
Developmental 















Key Findings Limitations 
 















parents: n = 31 
2) Heroin-
exposed group 



























the use of a 























(p < .01) and 
adopted and low 
SES children (p 


















to controls (p < 
.01), adopted and 
low SES children 
(p < .05), and 
children raised 
by addicted 



















Study Research design 
Developmental 















Key Findings Limitations 
  













group: n = 103 
18 months 
and 3 years 
































months and 3 
years old (p < 
.05)  
 
•Lack of blind 
assessors 

























































SDQ results did 
not indicate any 
difficulties on 










































Study Research design 
Developmental 















Key Findings Limitations 
 
Konijnenberg 
















































                       
The maternal risk 
model accounted 
for a significant 
amount of overall 
variance in 
internalising (p = 
.02) and 
externalising 





risk) model also 
explained a 
significant 
amount of the 
overall variance 
in internalising (p 
= .008) and 
externalising 




























n = 9 
3)Non-exposed 
comparison 








































drug use  
•Higher social 







Study Research design 
Developmental 




























n = 72 
2) Comparison 
group: n = 58 
 


















































problems (p = 
.05), attention 
problems (p = 
.005), and social 





•Lack of blind 
assessors 
•Small sample 
size in relation 




other drug use 
•Comparison 















n = 57 
2) Reference 



































higher scores of 
ADHD 
symptoms- 
Combined (p < 
.001), Inattention 
(p < .001), and 
Hyperactivity/ 


























Study Research design 
Developmental 















Key Findings Limitations 
 









n = 454 
2) Comparison 




































































For the first 6 
years of life, 
children exposed 
to opioids had 






(aOR = 2.13). 
For age 6 and up, 
children exposed 
to opioids had 



















drug use  






1.5  Methodological Issues in Behavioural and Emotional Adjustment Outcome Studies 
  
Most of the studies on the long-term consequences of prenatal opioid exposure all share 
common limitations. According to Azuine et al. (2019), there are significant gaps in the 
knowledge regarding the long-term consequences of maternal opioid use on the child’s 
neurodevelopmental outcomes, as large prospective cohort studies that investigate this issue 
are limited. Many studies are dated back to the 1970s and 1980s, have relied on maternal-self 
report measures and have used small sample sizes (Azuine et al., 2019). The more dated studies 
primarily focused on heroin exposure, followed by methadone (Woodward et al., 2018). 
Additionally, many studies have an inadequate or no control group, have high rates of attrition, 
report varying levels of methadone doses, and inadequately control for poly-drug use and other 
potential environmental/maternal confounding variables. The presence of multiple 
methodological issues can influence the validity and reliability of the conclusions drawn. 
Almost all existing studies are subject to a number of methodological issues. First, the 
issue of small sample size is prevalent in the previous literature. de Cubas and Field (1993) 
included  20 methadone-exposed children and 20 non-exposed children in their study. Wilson 
et al. (1979) included 77 children in their research sample but included only 22 children in the 
heroin-exposed group. Additionally, Konijnenberg et al. (2015) included 24 methadone-
exposed children and 11 buprenorphine-exposed children. Sundelin-Wahlsten and Sarman 
(2013) included 25 children in the buprenorphine-exposed sample and no comparison group. 
Small sample sizes can decrease statistical power, therefore creating difficulties with detecting 
significant associations. 
Another significant methodological issue affecting most existing research is the high 
rate of sample attrition observed over time. For example, Soepatmi (1994) had a retention rate 
of 43%, with only 67/157 children being followed-up for one year or more. Hunt et al. (2008) 






50% (67/133) of methadone-exposed children in the 3-year follow-up. Retention of participants 
in drug outcome studies is difficult due to a drug-using lifestyle and culture being associated 
with social disruption (Hunt et al., 2008). Nygaard et al. (2016) lost 26 children to follow up at 
8 ½ years. This can often lead to selective sample loss since those families that were most at 
risk of being lost to follow-up are likely to be those at greatest risk. For example, Azuine et al. 
(2019) did not obtain medical records for 47 children in the first six years and did not obtain 
medical records for 762 children aged six years and above. This could have potentially led to 
an underestimation of mental health diagnoses in opioid-exposed children. This systematic 
sample loss and attrition can, in turn, undermine sample representativeness and the 
interpretation and generalisability of study results. Additionally, and importantly, the loss of 
study participants can also reduce statistical power.  
Some studies did not include an adequate comparison group or did not include one at 
all (Soepatmi, 1994; Sundelin-Wahlsten & Sarman, 2013). Sundelin-Wahlsten and Sarman 
(2013) and Soepatmi (1994) referenced results to previous research. Additionally, some studies 
included comparison groups but did not adequately match them (Konijnenberg & Melinder, 
2015). Without an adequate comparison group, it is difficult to determine if the outcomes are 
due to the prenatal methadone exposure or if they are due to other risk factors. Comparison 
groups are important to include in a study to help control for validity threats and to extrapolate 
from the results. 
Another important limitation of existing studies examining the long-term outcomes of 
prenatal methadone exposure is the varying levels of methadone dosages that were 
administered to women during pregnancy. In addition, many studies did not state the 
methadone dose levels at all (de Cubas & Field, 1993; Hunt et al., 2008; Soepatmi, 1994; van 
Baar et al., 1994). Konijnenberg et al (2015) reported an average methadone dose at birth of 






dosages, this could result in differing developmental outcomes for the child. Additionally, 
average methadone doses during pregnancy have increased over the years (Wouldes & 
Woodward, 2010), which can make it difficult to compare the findings of newer studies to the 
findings of more dated studies due to different dosage levels.  
Some studies gathered maternal drug-use information from maternal self-report 
measures and structured interviews which could result in validity concerns and potential bias 
in the responses (Azuine et al., 2019; Konijnenberg et al., 2015; Konijnenberg & Melinder, 
2015; Nygaard et al, 2016; Ornoy et al., 2001). For example, de Cubas and Field (1993) 
gathered poly-substance use information via maternal self-report, however, the measure was 
not specified any further. The nature of maternal self-report could compromise the accuracy of 
the results due to systematic biases. Some previous studies have utilised a multi-method 
approach consisting of maternal self-report, maternal and child clinical records, and 
toxicological analysis of maternal urine during pregnancy and infant meconium after birth 
(Hunt, 2008), which assisted in determining important information about the substances used 
during pregnancy. Under-reporting and under-estimation when utilising self-report measures 
is also a potential risk factor within the previous research. Some previous studies conducted in 
countries such as the U.S.A, where there is mandatory reporting of drug use, may have 
encountered issues with under-reporting on maternal self-report measures of poly-drug use. 
Due to the criminalization of drug use during pregnancy, this could deter women from 
reporting their drug use. Additionally, it has been found that people who frequently use drugs 
tend to under-report the frequency and amount of their substance use compared to occasional 
drug users, possibly due to stigmatisation concerns or embarrassment (Garg et al., 2016). 
Additionally, some studies relied on retrospective reports of maternal drug use during 
pregnancy (de Cubas & Field; Ornoy et al., 2001; Wilson et al., 1979). Retrospective accounts 






Results on the long-term outcomes of children who have been born to women who have 
used opioids while pregnant can be difficult to interpret due to the challenges associated with 
understanding the impact of other drug exposure and additional environmental factors 
(Sundelin-Wahlsten & Sarman, 2013). Poly-substance use is common within women 
dependent on opioids (Jansson et al., 2019). Among previous research, the additional use of 
alcohol, tobacco, marijuana and other drugs has been commonly reported amongst women who 
have used opioids during pregnancy. The use of multiple substances is more common than the 
use of a singular drug in treatment population studies (Jansson et al., 2011). de Cubas and Field 
(1993) matched the target and control group on alcohol and cigarette use. However, no other 
studies controlled for poly-drug use during pregnancy. Multiple studies contained uncertainty 
about the extent of poly-drug exposure (de Cubas & Field, 1993; Sandtorv et al., 2018; Wilson 
et al., 1979), or did not state the presence of poly-drug use at all (Hunt et al., 2008; Soepatmi, 
1994). Azuine et al. (2019) defined substance exposure heterogeneously which included 
unknown, illicit and therapeutic opioid exposures that lead to a diagnosis of NAS. Due to 
heterogeneity, long term effects of opioid exposure could be difficult to differentiate, creating 
uncertainty around the effects of specific opioids (Azuine et al., 2019). Additionally, it remains 
relatively unknown how maternal multiple drug use during pregnancy in the absence of 
methadone, or in addition to methadone affects the developing child (Jansson et al., 2011). 
Lastly, a major limitation in the published research on the emotional and behavioural 
outcomes of children prenatally exposed to opioids is the lack of consideration of 
environmental factors that may also influence development. Common maternal and family risk 
factors that are correlated with maternal opioid use include mental health issues, family 
violence, poverty, lack of social support and low socioeconomic status (Nygaard et al., 2016). 
These factors have also been found to contribute to behavioural and emotional adjustment 






included multiple groups of differing environments to attempt to disentangle the effects of the 
substance and the pre/postnatal environment (Ornoy et al., 2001; Wilson et al., 1979). Some 
studies also matched their participants on various factors to attempt to control for confounding 
variables (de Cubas & Field, 1993; Hunt, 2008; Sandtorv et al., 2018; Wilson et al., 1979). 
However, numerous studies have not adequately controlled for confounding 
environmental/maternal factors and the use of multiple substances in their statistical analyses 
(de Cubas & Field, 1993; Soepatmi, 1994; Sundelin-Wahlsten & Sarman, 2013; van Baar et 
al., 1994). This is important because it makes the relationship between drug exposure and the 
observed outcomes unclear, as disentangling the effects of prenatal methadone exposure and 
the effects of environmental factors can be difficult. Without adequate controlling of 
confounding factors, group differences can be subject to overestimation. Some studies 
controlled for various confounding factors in their analysis (Azuine et al, 2019; Konijnenberg 
& Melinder, 2015; Nygaard et al, 2016; Wilson et al., 1979). Although these studies had 
adjusted for various socio-familial/infant factors, they did not control for poly-drug use during 
pregnancy. These studies were mainly published in recent years compared to the remaining 
studies that did not consider confounding variables.  
1.6  Conceptual Framework 
 
As foetal neuroanatomical growth is occurring in-utero, drug exposure may disturb 
specific events in brain development (Woodward et al., 2018). In-utero exposure to drugs can 
have long-term implications for the child’s neurological functioning and structure (Ross et al., 
2015). Approximately two weeks after conception, the human brain starts to develop (Bick & 
Nelson, 2016). During the prenatal period, the central nervous system undergoes multiple 
developmental processes. These processes include neural induction, neurulation, proliferation, 






& Nelson, 2001). Therefore, this period of neurological development is a particularly 
vulnerable period for the developing foetus. Prenatal exposure to substances during this 
sensitive period of brain development can have both direct and indirect effects on the foetal 
brain and may disrupt the developmental trajectory. Substances can directly affect the 
developing foetus through placental transfer and indirectly through the alteration of maternal 
physiology (Szeto, 1995).  Lifestyle factors that may accompany mothers who use drugs during 
pregnancy can also increase the child’s vulnerability to adverse outcomes.  
1.6.1  Direct Pathway  
Prenatal opioid exposure can directly influence neurodevelopment in-utero. The direct 
pathway refers to the distribution of opiates across the placenta to the developing foetus (Szeto, 
1995). Essentially, the substance crosses the placenta and directly affects the development of 
the foetus. Direct effects of drug exposure on the developing brain vary according to the timing 
of exposure during gestation, drug type, polypharmacy, the extent of drug distribution and 
dosage level (Woodward et al., 2018). The stage of foetal development, as well as the 
sensitivity of the nervous system and different brain regions to different teratogens, may also 
influence the trajectory of brain development (Woodward et al., 2018).  
1.6.2  Indirect Pathway 
In addition to the direct effects of prenatal opioid exposure on foetal/infant brain 
development and behaviour, opioids can indirectly affect foetal neurodevelopment through the 
impact on other physiological systems (Woodward et al., 2018). Opioids can alter maternal-
placental physiology (Szeto, 1995). Adverse outcomes after prenatal opioid exposure can be 
secondary to alterations in maternal physiology (Ross et al., 2015; Szeto, 1995), and exposure 
can compromise the delivery of substrates and oxygen to the foetus (Szeto, 1995). Since many 






al., 2018), the occurrence of poly-drug use can make it difficult to determine the indirect effects 
of each drug. The indirect pathway also includes the influence of other environmental and 
maternal lifestyle factors on the developing child. Increased mental health behaviours caused 
by addiction and increased production of stress hormones are examples of maternal 
physiological characteristics that can secondarily alter foetal development (Ross et al., 2015). 
Children who have been prenatally exposed to methadone are often exposed to the effects of 
maternal emotion dysregulation and psychopathology, problematic maternal interactions, and 
poverty (Hans & Jeremy, 2001). Additionally, high levels of early psychosocial stress can 
influence foetal development, with findings suggesting that prenatal stress can exert 
programming effects on the stress response and neuroendocrine systems (Conradt, Crowell, & 
Lester, 2018). Developmental outcomes such as behavioural and emotional maladjustment in 
opioid-exposed children are likely the result of both biological and environmental risk factors. 
Figure 1 illustrates the complex interplay of factors and processes that can contribute to early-














Figure 1  
Model of Potential Factors Involved in the Mental Health Outcomes of Methadone-Exposed 









1.6.3  Neurosequential Model 
  
The Neurosequential Model, a sequentially-organising functional model of the brain, 
provides a useful framework for mapping the neurological development of children exposed to 
prenatal and postnatal trauma (Hambrick, Brawner, & Perry, 2019). Adverse experiences such 
as prenatal exposure to drugs can influence the developing brain and can disrupt a typical 
trajectory of neurodevelopment, resulting in atypical patterns of neurohormonal and neural 
activity (Perry, 2009). According to this model, the brain is organised hierarchically, with the 
lower parts of the brain mediating basic regulatory functions and the higher parts of the brain 
mediating complex functions such as abstract thinking (Perry & Hambrick, 2008). The lower 
sections of the brain are the first to develop, as the brain develops in a bottom-up sequence. 
The limbic system, located above the brainstem and below the cerebral cortex, controls 
functions such as affect, relational functioning and attunement (Perry, 2013). The brain 
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continues to grow and organise itself, proceeding up through to the complex sections of the 
brain (Perry, 2006).  
Intrauterine insults can affect norepinephrine, dopamine and serotonin systems of the 
brainstem and diencephalon, which undergo rapid organisation during the early years of life 
(Perry & Hambrick, 2008). Brainstem and diencephalon development is related to issues with 
attention, impulsivity and self-regulation (Perry, 2009).  If the lower sections of the brain that 
are responsible for stress response systems are disrupted by intrauterine insults during 
development, disorganisation and dysregulation of the higher regions of the brain can occur 
(Perry, 2006). This can lead to observed difficulties in various areas of functioning, including 
behavioural and emotional regulation. Additionally, various studies have reported significant 
difficulties in cognitive and motor functioning for opioid-exposed children, which further 
demonstrates the cascade effect of intrauterine trauma. Therefore, such impairment in brain 
development may function as a potential causal mechanism contributing to behavioural and 
emotional maladjustment that can be observed in ME children. Postnatal adverse experiences 
such as attachment disruptions and traumatic stress can also disrupt typical brain development.  
This can result in a cascade of neurodevelopmental outcomes such as behavioural, social and 
emotional dysregulation and impaired speech and motor functioning (Perry, 2009). Since 
children born to methadone-maintained mothers are likely to be born into high social risk 
contexts, this may increase their risk of adverse postnatal experiences that may influence 
neurodevelopment. 
1.7  Socio-Familial Factors 
It is important to note some of the significant maternal and socio-familial risk factors 
that can contribute to the relationship between prenatal methadone exposure and later 
behavioural and emotional adjustment in preschool children. Although MMT for pregnant 






drug use for both the mother and developing foetus, multiple risk factors can be concurrent 
with MMT. In comparison to the general population, women enrolled in MMT have been found 
to have increased levels of adverse birth and maternal outcomes (Davie-Gray, Moor, Spencer, 
& Woodward, 2013; Patrick, Schumacher, Benneyworth, Krans, McAllister, & Davis, 2012). 
Maternal psychopathology is a significant predictor of later behavioural and emotional 
adjustment in children and is highly correlated with MMT during pregnancy. In the same 
cohort as the present study, Davie-Gray et al. (2013) found that 43% of MMT women 
experienced depressive symptoms that met criteria for probable clinical depression and had 
high levels of poly-drug use during pregnancy (Davie-Gray et al., 2013). Approximately 12% 
of MMT women were taking prescribed benzodiazepines and 3.7% of MMT women were 
using prescribed antipsychotic medication during pregnancy, compared to no comparison 
women (Davie-Gray et al., 2013). These findings represent the level of comorbidity between 
substance dependence and psychiatric disorder in methadone-maintained (MM) women 
(Davie-Gray et al., 2013). Children with mothers who are depressed and/or anxious are at a 
higher risk of an array of behavioural outcomes such as withdrawal, antisocial behaviour, 
acting out, and further psychiatric and emotional issues (Najman, Bor, Andersen, O’Callaghan, 
& Williams, 2000).  
Other biological factors that can influence the development of behavioural outcomes 
include child sex and maternal nutrition during pregnancy. Sex differences in the prevalence 
and presentation of behavioural and emotional adjustment difficulties have been observed. 
Specifically, boys are diagnosed with ADHD at a higher frequency compared to girls at a ratio 
of 2:1 (American Psychiatric Association, 2013). Both ODD and CD are reportedly more 
prevalent in boys (Maughan, Rowe, Messer, Goodman, & Meltzer, 2004). Additionally, the 
lack of prenatal exposure to sufficient nutrients may also affect neurodevelopment in-utero and 






pregnancy may be at an increased risk of having a poor diet during pregnancy (Levine and 
Woodward, 2018; Tomedi, Bogen, Hanusa, Wisner, & Bodnar, 2012). A weak but robust 
association between better maternal diet and lesser behavioural problems in the child has been 
reported (Borge, Aase, Brantsaeter, & Biele, 2017). Although the association is not strong, this 
suggests there may be a relationship between maternal nutrition during pregnancy and 
neurodevelopmental outcome.  
As evidenced in the previous literature review, women enrolled in opioid maintenance 
treatment programs are likely to be using multiple other drugs during pregnancy, such as 
marijuana, benzodiazepines, tobacco, alcohol and amphetamines (Konijnenberg et al., 2015; 
Levine & Woodward, 2018). The use of multiple drugs during pregnancy in addition to 
methadone negatively influence neurodevelopment and subsequently could lead to behavioural 
and emotional issues later in life. The interactive or additive effect of multiple substances may 
result in outcomes that differ from the effect of solely opioids (Larson et al., 2019).  
A variety of social risk factors have been linked to the development of externalising 
behaviour problems in preschool children. Davie-Gray et al. (2013) investigated the 
characteristics of pregnant women receiving MMT and found mothers enrolled in MMT had 
significantly higher levels of psychosocial and maternal risk factors compared to non-exposed 
comparison women. Methadone-maintained women had significantly higher levels of social 
adversity during pregnancy, such as welfare dependency, no formal qualifications and were 
less likely to be in a stable relationship (Davie-Gray et al., 2013). Burke, Loeber, and Birmaher 
(2002) noted several socioeconomic factors associated with disruptive behaviour amongst 
children, such as parental unemployment and low SES. Children from families of lower SES 
are at an increased risk of behavioural adjustment difficulties (Hosokawa & Katsura, 2018; 
Loeber, Burke, Lahey, Winters, & Zera, 2000; Najman et al., 2000). Low SES is also correlated 






2000). A combination of socio-familial factors such as the factors discussed may heighten the 
risk of poor neurodevelopmental outcomes in opioid-exposed children. 
1.8  Study Aims 
The overall aim of this thesis was to assess the extent to which children exposed 
prenatally to methadone might be at increased risk of experiencing a range of early-onset 
psychiatric disorders that are relatively rare in younger children. Disorders examined spanned 
both clinically significant externalising and internalising problems and disorders, including 
rates of DSM-IV diagnoses of Oppositional Defiant Disorder (ODD), Attention-Deficit 
Hyperactivity Disorder (ADHD), Conduct Disorder (CD), Anxiety Disorders, Depression and 
Autism Spectrum Disorder (ASD). Previous research based primarily on parent-report shows 
that children exposed prenatally to opioids are found to have higher levels of hyperactivity, 
attention problems and impulsivity (Nygaard et al., 2016; Ornoy et al., 2001; Sandtorv et al., 
2018; Sundelin-Wahlsten & Sarman, 2013), as well as other externalising behaviour 
difficulties such as conduct problems (Azuine et al., 2019) and social difficulties (de Cubas & 
Field, 1993; Hunt et al., 2008; Nygaard et al., 2016; Soepatmi, 1994). Although there is less 
evidence for internalising difficulties, some studies have reported increased levels of depressed 
mood and anxiety in opioid-exposed children (de Cubas & Field, 1993; Ornoy et al., 2001). 
However, little is known about the extent to which these children are at risk of later meeting 
DSM-IV criteria for mental health or psychiatric disorder, or how these difficulties may present 
at an early age. Therefore, the specific aims of this thesis were as follows.  
1. To examine the extent of parent-reported behavioural and emotional difficulties at age 
4.5 years in a cohort of children who were prenatally exposed to methadone compared 






child behavioural and emotional adjustment problems were measured using the parent-
completed Strengths and Difficulties Questionnaire (SDQ).  
2. To assess the extent to which 4.5-year-old ME children were subject to a DSM-IV 
psychiatric disorder relative to non-exposed comparison children. The risk of 
externalising and internalising disorder diagnoses was measured using the 
Development and Well-Being Assessment (DAWBA), with diagnoses assigned by a 
registered clinical psychologist (SA) for all children. 
3. Assess the extent and patterns of psychiatric comorbidity in children prenatally exposed 
to methadone. That is, the degree to which children in each group might meet the 
criteria for two or more psychiatric disorders and the nature of these comorbidities.  
4. Examine the extent to which observed associations between prenatal methadone 
exposure and later psychiatric risk might be explained by confounding factors 
correlated with maternal methadone use during pregnancy. Confounding factors were 
identified based on previous research and theory and included maternal psychiatric 
illness during pregnancy, social risk, child sex, birth weight, maternal poly-drug use 
















2.1  Research Design  
This study draws on quantitative data from a prospective longitudinal study, the 
Canterbury Methadone in Pregnancy (MIP) study. The overall goal of the MIP study is to 
understand the developmental outcomes of children born to mothers maintained on methadone 
during pregnancy. The data that will be used in this sub-analysis were collected at age 4.5 years 
as part of a comprehensive child neurodevelopmental assessment at the Canterbury Child 
Development Research House, located on campus at the University of Canterbury, 
Christchurch. Prior to the 4.5-year- assessment wave, data on both ME and NE comparison 
children were collected at three separate time points (birth, 18 and 24 months).  
 Around the time of birth, detailed information about each mother’s personal, social 
and pregnancy background was collected as part of an extensive interview conducted by a 
senior neonatal research nurse. This information was combined with data from maternal and 
infant medical records, in addition to a toxicological analysis of maternal urine samples during 
pregnancy and infant meconium analysis after birth.  
At the 18-month assessment, parent-child interaction observations were recorded and 
measures of familial circumstances and other psychosocial characteristics were administered 
during the maternal interview. This home visit was then followed six months later with a clinic-
based neurodevelopmental evaluation when children turned two years old. 
The 4.5-year evaluation assessed various aspects of familial/maternal circumstances 
and child neurodevelopment. The present study focuses on two key measures of behavioural 
and emotional adjustment that were administered as part of the 4.5-year follow-up interview 
with each study child’s primary caregiver. Provided below is a description of the present study 






2.2  Study Sample 
The study sample comprised two groups of 4.5-year-old children who were born at 
Christchurch Women’s Hospital (n = 190). All mothers were recruited during pregnancy or at 
birth from Christchurch Women’s Hospital between 2003 and 2008. Exclusion criteria for both 
groups of children included an HIV positive diagnosis, a diagnosis of Foetal Alcohol Syndrome 
(FAS), very preterm birth (≤32 weeks), congenital abnormalities, and non-English speaking 
parents. Children with severe Autism and developmental delays were also excluded from the 
study.  
2.2.1  Methadone-Exposed Group  
The first group, the methadone-exposed group (ME) (45.8% of the sample), consisted 
of 87 children born to mothers enrolled in the Christchurch Methadone Programme during 
pregnancy from 2003 to 2008. The Christchurch Methadone Programme works in partnership 
with the antenatal obstetric team at Christchurch Women’s Hospital. This service includes 
access to Methadone Maintenance Treatment and antenatal support for women dependent on 
opioids during pregnancy. At birth, 106 ME infants were initially identified. To be included in 
this study, women in the ME group were required to be enrolled in MMT during pregnancy 
and meet the above inclusion criteria. At the time of the 4.5-year assessment, 19 children had 
died or been lost to follow-up. Figure 2 presents the study design and the reasons for sample 
attrition at the time of the 4.5-year assessment. A total of 86 mothers with 87 children (one set 
of twins) completed parental/primary caregiver interview and were included in this analysis 
(81%). The ME child group included 51 males (58.6%) and 36 females (41.4%). Information 
about the maternal daily methadone administration during pregnancy was obtained via hospital 
and drug service records. The average methadone treatment dose for women during their third 






2.2.2  Non-Exposed Comparison Group  
The second group, referred to as the non-exposed comparison group, consisted of 103 
non-methadone exposed children aged 4.5 years old (54.2% of the sample). Non-exposed 
children were born to women who were randomly identified from the Christchurch Women’s 
Hospital delivery booking schedule and were then invited to participate in the initial parent 
interview at or close to the birth of their infant/s. The women included in the comparison group 
were representative of pregnant women in the Canterbury region, according to comparisons of 
the socioeconomic profile to regional census data. At birth, 115 comparison infants were 
initially identified. Twelve children did not participate in the 4.5-year follow-up, resulting in 
103 comparison children completing the follow-up assessment (90%). Reasons for attrition are 
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2.3  Procedure 
Mothers were contacted in person or by telephone when their child was as close as 
possible to age 4.5 years old and invited to participate in a follow-up child developmental 
evaluation. Each mother who participated in this study provided informed consent. Each 
evaluation consisted of one developmental assessment session at the Canterbury Child 
Development Research House, which took approximately four hours. Child assessment 
measures were selected to provide a comprehensive descriptive evaluation of children’s mental 
health, neuropsychological and motor development, in addition to each child’s caregiving 
environment. Breaks were provided as needed, and if necessary, completed across two 
sessions. All measures were administered by appropriately trained research staff and students 
with postgraduate or professional qualifications. The trained clinical psychologist who 
assigned diagnoses was blind to group membership. Research staff/students received training 
and were regularly supervised by the study principal investigator (LW) in the administration 
of all assessment procedures.  
2.4  Ethics Approval 
Ethics approval for this study was obtained from the Canterbury Regional Ethics 
Committee (Ethics Ref: URB07/10/042). Informed, written consent was obtained from all 
mothers participating in the study (see Appendix C).  
2.5  Measures  
As part of a structured parent interview, a series of standardised questionnaire measures 
were administered, including the parent-report screening Strengths and Difficulties 
Questionnaire (SDQ). Following the completion of the SDQ, the DAWBA interview was 
administered during the interview. Custom written questions were included in the parental 






administered by the study coordinator who was a trained research nurse. The interview was 
completed in a private room adjacent to where their child was being tested. A video link was 
available between the two rooms so the parent could view their child at all times. The following 
key measures from this assessment were included in this analysis.  
2.5.1  The Strengths and Difficulties Questionnaire (SDQ) 
The SDQ is a widely used screening tool that consists of 5 subscales assessing the 
extent of conduct problems, hyperactivity/inattention, emotional symptoms, peer problems, 
and prosociality in children and youth aged 3-16 years old (Goodman, 2001). In the present 
study, the SDQ was utilised to provide a measure of parent-reported behavioural and emotional 
adjustment (see Appendix A). Parents, teachers and youth themselves can complete the 
questionnaire. The SDQ consists of 25 items that are rated on a 3-point Likert scale ranging 
from 0 “not true” to 2 “certainly true” (Goodman, 1997). Higher scores indicate increased 
difficulties for the conduct, hyperactivity/inattention, emotional symptoms and peer problems 
subscales, whereas lower scores on the prosocial subscale indicate difficulties with prosocial 
behaviour. Additionally, five items are presented as strengths and are then reverse-scored as 
problems.  
Items included in the SDQ measure both positive and negative attributes of the child 
(Goodman, 2001). The conduct problems subscale includes items such as “Often has temper 
tantrums or hot tempers” and “Often fights with other children or bullies them”. Items 
regarding non-compliance, lying and cheating, and stealing are also included within this 
subscale. The hyperactivity/inattention subscale focuses on inattentiveness, hyperactivity, and 
impulsiveness, with items such as “easily distracted, attention wanders” and “thinks things out 
before acting”. The emotional symptoms scale focuses on internalising difficulties, with items 
such as “many worries, often seems worried” and “many fears, easily scared”. Difficulties with 






and “rather solitary, tends to play alone”. Lastly, the prosocial scale includes items that indicate 
prosocial behaviours such as consideration of others and sharing.   
The groupings of selected SDQ items into subscales was based on diagnostic 
classifications and factor analyses (Goodman, 2001). Items for each subscale can be summed 
to create a scale score ranging from 0-10 (Goodman, 1997). A total difficulties score ranging 
from 0-40 can be computed by summing the children’s scores on the conduct problems, 
hyperactivity/inattention, emotional symptoms and peer problems subscales (Goodman, 1997), 
giving an indication of the children’s overall behavioural and emotional adjustment. The 
prosocial scale is not included in the total difficulties score as it is weakly associated with the 
risk of psychiatric disorder (Goodman, 2001). An impact supplement is included in extended 
versions of the SDQ. The impact supplement asks the respondent if they believe the child has 
significant difficulties, and if the respondent answers yes, they are asked further questions 
about the timeframe, child’s distress, impairment and burden (Goodman & Scott, 1999).  
SDQ bandings can organise children’s scores on each subscale as normal, borderline 
and abnormal (Kersten et al., 2016). The use of cut-points can identify children that fall within 
the clinically significant range. Impairment was defined utilising the most severe 10% cut-
point on each of the subscales and total difficulties score. In the present study, clinical cut-off 
variables were created for each subscale and the total difficulties score based on the 10% of 
comparison children with the most severe difficulties. This was done because of the availability 
of a comparison group and due to the young age of study children relative to the sample on 
which test norms were established. This is a well-accepted approach in the paediatric literature 
(Delobel-Ayoub et al., 2006; Woodward et al., 2009). On each subscale, a score equal to or 
greater than the 90th percentile indicated abnormal difficulties (conduct problems ≥3, 
hyperactivity/inattention ≥6, emotional problems ≥4, peer problems ≥3, prosociality ≤6, and 






increased risk of psychiatric difficulties, and each subscale has been associated with the 
relevant DSM-IV diagnoses (Goodman, 2001) 
The SDQ is a highly popular and accessible measure of child behavioural and emotional 
difficulties. There are multiple versions in different languages, which are used across many 
countries and populations (Palmieri & Smith, 2007).  The SDQ is also available online and is 
free of charge (Palmieri & Smith, 2007). Additionally, the psychometric properties of the SDQ 
have been extensively tested across a variety of settings (Vostanis, 2006).  
Reliability of the SDQ has been shown to vary. A meta-analytic review by Stone, Otten, 
Engels, Vermulst, and Janssens (2010) reported weighted mean internal consistency results 
from 26 studies on the parent-report SDQ, with hyperactivity/inattention having an internal 
consistency of 0.76, and the rest of the subscales having an internal consistency less than 0.70. 
The total difficulties and impact scores had an internal consistency above 0.80. In contrast, 
Croft, Stride, Maughan, and Rowe (2015) reported good internal consistency across the SDQ 
subscales administered to preschool children. Stone et al. (2010) also measured the test-retest 
reliability of the parent-report SDQ and reported average to levels of reliability over time. 
Although the internal consistency and test-retest reliability vary between subscales and studies, 
the reliability of the SDQ is satisfactory.   
An important aspect of the SDQ is its ability to strongly correlate with similar measures 
of child behaviour and emotional difficulties. The SDQ has been shown to highly correlate 
with the well-established Rutter Scale (Goodman, 1997), and the CBCL (Goodman & Scott, 
1999), suggesting the SDQ has good concurrent validity. In a systematic review by Kersten et 
al. (2016), most studies reported adequate specificity of the SDQ (>70%) and inadequate 
sensitivity (<70%), suggesting that some children with significant difficulties may be missed. 






populations, including low and high-risk children and other populations that are hypothesised 
to have different scores (Goodman & Scott, 1999; Kersten et al., 2016). 
2.5.2  The Development and Well-Being Assessment (DAWBA) 
The Development and Well-Being Assessment (DAWBA) is a semi-structured 
interview that provides DSM-IV and ICD-10 mental health diagnoses in children aged 2-17 
years (Goodman, Ford, Richards, Gatward, & Meltzer, 2000). The DAWBA was designed for 
a nationwide survey on a large sample of British children and adolescents, investigating 
common behavioural and emotional disorders (Goodman et al., 2000). In the present study, a 
trained interviewer administered the DAWBA to parents during the parental interview. 
Information from parents is then subsequently combined with teacher report and other clinical 
data to comprehensively assess the child’s difficulties in multiple settings and from a range of 
perspectives. 
The DAWBA assesses a range of child psychiatric diagnoses, which are assigned by 
experienced clinicians after reviewing the data. The key diagnoses generated by the DAWBA 
that were of interest in the present study were externalising disorders (ADHD, ODD, and CD) 
and internalising disorders (Major Depressive Disorder, Generalised Anxiety Disorder, 
Separation Anxiety Disorder, Specific Phobia, and Social Phobia). When administering the 
DAWBA, the interviewer asks parents about the symptoms and criteria required for a DSM-
IV or ICD-10 diagnosis (see Appendix B). This includes the significant impact and impairment 
associated with the symptoms, which is necessary for a psychiatric diagnosis. According to the 
“skip rule”, the interviewer can skip the questions in a section unless enough of the initial 
screening questions are positive (Goodman et al., 2000). If positive, the parent is asked 
structured questions about the symptoms, which is supplemented by further semi-structured 
information about the child’s difficulties in the parent’s own words (Goodman et al., 2000). 






algorithm which predicts the probability of having a DSM-IV/ICD-10 diagnosis 
(www.dawba.net). The computer prediction assigns probability bands to each child, which 
range from 0.1% to >70%, representing the probability of having a psychiatric 
diagnosis/diagnoses. After reviewing the provisional computer-generated diagnosis, a 
qualified clinician would decide whether to accept or reject the risk of disorder based on 
additional data gathered on each child, which included information from the parental interview. 
Therefore, the final diagnostic decision was made by the clinician.   
Strengths of the DAWBA in clinical work include its mixture of open-ended and 
structured questions which means that the descriptions of the respondent’s problems in their 
own words can be reviewed (Aebi, Kuhn, Metzke, Stringaris, Goodman, & Steinhausen, 2012). 
Additionally, all major DSM-IV diagnoses are covered, as well as coexisting diagnoses that 
could be missed during the interview (Aebi et al., 2012). Finally, the DAWBA can be 
conveniently administered over the internet (Aebi et al., 2012). 
In terms of reliability, less research has been published on the inter-rater and test-retest 
reliability, as most research has focused on validity. Aebi et al. (2012) conducted a randomised 
trial of the DAWBA in a clinical sample and noted satisfactory inter-rater reliability of both 
internalising and externalising disorder diagnoses, suggesting that there is substantial 
agreement amongst clinical interviewers. 
Goodman et al. (2000) provided evidence that supports the validity of the DAWBA. 
Compared to the community sample, there were significantly higher psychiatric disorder rates 
in the clinic sample (Goodman et al., 2000). Goodman et al. (2000) reported approximately 
89% specificity in the community sample and 92% sensitivity in the clinical sample of children. 
Within the community sample, children with and without DAWBA diagnoses differed on 






the clinical sample, DAWBA diagnoses were in agreement with the children’s clinical case 
notes, suggesting the DAWBA compares well to other forms of psychiatric assessment.   
2.5.3  Measures of Confounding Maternal and Birth Characteristics 
As noted previously, a maternal interview was administered during pregnancy or at 
birth to gather information about each woman’s familial circumstances and personal 
background, as well as maternal substance use, mental health and nutrition (copy of maternal 
interview available on request). Data on infant characteristics such as sex and birth weight were 
also recorded from hospital records.  
Maternal Social Risk at Birth  
For data reduction purposes, a composite measure of maternal social risk was created 
by summing five dichotomously scored maternal social factors. These five dichotomous social 
risk factors included early maternal age (1= < 21 at the time of birth), minority ethnicity (1= 
Māori, Pacific Islander, Asian or African), low maternal education level, single parenthood, 
and family SES. SES was measured using the Elley-Irving Socio-Economic Index, which 
classified families as low SES if they were unemployed or working unskilled, semi-skilled, or 
skilled jobs. Families were classified as high SES if they were working managerial, technical, 
or professional jobs.  
Maternal Substance Use During Pregnancy 
The use of substances such as alcohol, cigarettes, cannabis, benzodiazepines, 
stimulants, and other opiates (other than prescribed methadone) was recorded via maternal self-
report, random maternal urine toxicology analysis during pregnancy and infant meconium 
samples at birth. The use of self-report measures of substance use as well as analysis of 
maternal urine and infant meconium helped to verify the accuracy of self-reported drug use. 
Maternal wellbeing was also assessed in the maternal interview. 






 Maternal depression was measured using the Edinburgh Postnatal Depression Scale 
(Cox, Holden, & Sagovsky, 1987). Mothers were also asked if they had been treated for any 
psychiatric illness during pregnancy.  
A series of questions related to nutrition during pregnancy was also included in the 
interview, such as the average total weekly servings of vegetables, meat, fruit, eggs, bread, 
milk and cereals.  
2.6  Data analysis 
The data in this study were analysed using SPSS Statistics Version 25. The p < .05 
significance level was used to detect statistical significance. The analysis was done in three 
steps. First, between-group differences in the child and family characteristics of the two study 
groups were compared using independent samples t-tests for continuous variables or the chi-
squared statistic for dichotomous variables. Second, between-group differences in the 
behavioural and emotional outcomes of study children as measured using the SDQ and 
DAWBA were assessed using similar statistical methods. Depending on the distributional 
properties of the outcome variable of interest, Cohen’s d or the Odds Ratio will be used to 
provide a measure of the effect size of the extent of the difference in means between the two 
groups. The third step in the analysis examined the extent to which significant relationships 
between prenatal methadone exposure and children’s later mental health outcomes reflected a) 
the direct effects of methadone exposure during pregnancy and/or b) the effects of confounding 
maternal and other adverse pregnancy factors correlated with maternal methadone treatment 
during pregnancy. A wide range of possible confounders was considered. These were identified 
from previous literature on factors correlated with MMT during pregnancy and child 
adjustment outcome, as well as an examination of their relationship with prenatal methadone 
exposure in the present study, as shown in Table 2. These analyses involved the use of multiple 






predict the psychiatric outcomes of children at 4.5 years, even after significant confounding 
factors were statistically controlled for. Since the dependent variables in this analysis were 






























3.1  Sample Characteristics 
 3.1.1  Maternal Social Background and Pregnancy Characteristics 
Table 2 describes the social background and pregnancy characteristics of mothers in 
the two study groups. Significant between group differences were found across all maternal 
variables, except for rates of young motherhood < 21 years of age (p = .63). Specifically, 
methadone-maintained mothers were younger at birth (p = .01) and were more likely than 
comparison mothers to be a single mother (p < .0001).  They were also more likely to have no 
educational qualifications (p < .0001) and living in low SES circumstances (p < .0001). During 
pregnancy, MM mothers had higher rates of psychiatric illness (p < .0001), more symptoms of 
depression based on their EPDS scores (p < .0001), and had a lower quality food diet (p < 
.0001) during pregnancy. These findings suggest women enrolled in MMT during pregnancy 
were obstetrically and socially a high-risk population.  
 
Table 2 









(n = 103) 
 
t/χ2 p 
M (SD) Maternal 
Age 29.81 (5.34) 31.75 (5.33) -2.50 .01 
% Young Mother 
<21 years 3.4 4.9 .23 .63 
% No School 
Qualification  80.5 19.4 70.49 < .0001 
% Single Mother  49.4 9.7 36.99 < .0001 







Table 3 examines the ethnicity of MM mothers and comparison mothers. As shown, 
the ethnic profile of the two groups differed significantly (p = .01). Specifically, the majority 
of mothers’ in both study groups self-identified as of NZ European/other European descent 
(77% and 81.6%, respectively). The ethnic backgrounds of mothers in the comparison group 
were more ethnically diverse than the methadone in pregnancy group, however, there were 
more Māori mothers in the MM group compared to the comparison group (23% and 10.7%, 
respectively). Approximately one quarter of MM mothers were of Māori descent compared to 
10.7% of comparison mothers. A small proportion of comparison mothers were of Pacific 
Islands ethnicity and approximately 7% of comparison mothers were of “other” ethnicity, 
predominantly of Asian/African descent. No MM mothers self-identified within these two 
categories. 
 
   Table 3 
   Ethnicities of Mothers Maintained on Methadone and Comparison Mothers 
   Note: χ2 = 11.26 (3); p = .01 
% Any Psychiatric 
Illness  57.0 16.7 33.28 < .0001 
% Positive EPDS 
Score ≥ 13  61.2 12.6 48.54 < .0001 
M (SD) Nutrition 
Score  56.6 (20.9) 90.8 (25.4) -10.21 < .0001 
Maternal Ethnicity 
MM 
(n = 87)  
(%) 
Comparison 
(n = 103) 
(%) 
New Zealand European/Other European 77.0 81.6 
Maori  23.0 10.7 
Pacific Islander 0.0 1.0 
Other 0.0 6.8 






3.1.2  Substance Use During Pregnancy 
The use of other licit and illicit drugs besides methadone during pregnancy was also 
carefully documented. As shown in Table 4, mothers maintained on methadone had 
significantly higher rates of both licit and illicit drug use during pregnancy compared to 
comparison mothers. This was observed for all drugs excluding alcohol use during pregnancy, 
which did not differ significantly between MM mothers (17.2%) and comparison mothers 
(20.4%). In contrast, there was a large difference between MM mothers’ cigarette use during 
pregnancy (92%) compared to comparison mothers’ cigarette use during pregnancy (15.5%). 
Methadone-maintained mothers also smoked more cigarettes each day compared to 
comparison mothers (p < . 0001). In terms of prescribed drugs, 13.8% of MM mothers used 
prescribed benzodiazepines during pregnancy, compared to no comparison mothers (p < 
.0001). Finally, no significant between group differences were found in the use of prescribed 
Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants during pregnancy (p = .29).  
 
Table 4 
Rates of Poly-Substance Use in Mothers Maintained on Methadone and Comparison Mothers 
Maternal Drug Use During 
Pregnancy 
MM Mothers 
(n = 87) 
Comparison 
Mothers 
(n = 103) 
         χ2 p 
(%) Alcohol 17.2 20.4 .30 .58 
(%) Cigarettes 92.0 15.5 110.19 <.0001 
M(SD) Daily cigarette use 
across pregnancy 13.02 1.42 11.08 <.0001 
(%) Cannabis 48.3 1.0 60.28 <.0001 
(%) Illicit benzodiazepines  27.6 0.0 32.52 <.0001 






(%) Stimulants  19.5 0.0 22.10 <.0001 
(%) Prescribed 
Benzodiazepines 13.8 0.0 15.17 <.0001 
(%) Prescribed SSRIs 32.2 25.2 1.12 .29 
 
3.1.3  Infant Characteristics 
As shown in Table 5, there was a tendency for MM mothers to deliver earlier than 
comparison mothers but this difference did not reach statistical significance (p = .09). They 
did, however, deliver infants with significantly lower birth weights (p < .0001), smaller head 
circumferences (p < .0001) and were shorter in length (p < .0001) than comparison infants. 
Also as expected, 87.4% of ME children received treatment for NAS and no comparison 
children received treatment for NAS (p < .0001).  
 
Table 5 
Characteristics of ME and Comparison Infants at Term 
 
Infant Clinical 
Data at Term 
ME 
(n = 87) 
Comparison 
(n = 103) t/ χ2 p 
(%) NAS 




38.79 (1.71) 39.21 (1.72) -1.71 .09 
M (SD) Birth 




33.84 (1.53) 34.67 (1.47) -3.80 <.0001 
M (SD) Birth 






3.2  Parent-Reported Child Behavioural and Emotional Adjustment at Age 4.5 Years 
Table 6 describes the behavioural and emotional adjustment of the two study groups 
based on parent ratings on the SDQ at age 4.5 years. Significant differences were found across 
all scale scores, with parents of ME children being significantly more likely to report higher 
levels of child conduct, hyperactivity/inattention, emotional, peer and prosocial behaviour 
difficulties than parents of comparison children. The highest mean difference was reported on 
the hyperactivity/inattention scale of the SDQ, with a mean difference of 1.86 (p < .0001). The 
mean difference for conduct problems between the ME and comparison children was also high 
(mean difference= 1.55; p < .0001). Methadone-exposed children also had significantly more 
peer problems than comparison children, with a mean difference of 0.65 (p = .002). Methadone-
exposed children and comparison children had a similar mean difference in emotional 
difficulties (mean difference= 0.64; p = .01). In terms of prosocial behaviour, ME children 
obtained a significantly lower prosocial score than comparison children (mean difference= -
0.91; p < .0001). A large mean difference of 4.70 (p < .0001) for the total difficulties score was 
observed for ME and comparison children. Not surprisingly given the above findings, parents 
of ME children reported higher levels of distress and impairment associated with their child’s 
difficulties as indicated by their higher impact scores, relative to parents of comparison children 
(mean difference= 0.60; p = .001).  
 
Table 6 
Parent-Reported Behavioural and Emotional Functioning of ME and Comparison Children at 
Age 4.5 Years 
SDQ Scores 
ME 


































Extending on the above analysis, we then examined the extent to which ME children 
had emotional and behavioural problems in the clinical range on the SDQ. These results are 
shown in Table 7, which reports the proportion of children whose scores placed them in the 
clinically at-risk range. As described in the Method, children were classified as falling within 
the clinical range if their scores exceeded the tenth percentile score of children in the 
comparison group (See page 52). That is, the abnormal range was specified according to the 
cut-point which separated the comparison children with scores in the most severe 10%.  
All subscale scores excluding the emotional symptoms score (p = .05) resulted in 
statistically significant differences between the rates of clinical-range scores for ME and 
comparison children at age 4.5 years. The largest difference was between the ME and 
comparison children on the conduct problems subscale, with 42.5% ME and 10.7% comparison 
children falling within the abnormal range. Methadone-exposed children had 6.2 times the odds 
of scoring within this range (p < .0001). The hyperactivity/inattention subscale also resulted in 
clear between-group differences (p = .003), as ME children (27.6%) had 3.2 times the odds to 

















































































exposed children (23%) had 2.5 times the odds of having scores within the abnormal range for 
peer problems than comparison children (10.7%) (p = .02). The prosocial subscale also resulted 
in statistically significant differences between ME (21.8%) and comparison (6.8%) children 
(OR= 3.83; p = .003). Although there were observed differences between ME and comparison 
children in emotional symptoms, this different was not statistically significant (p = .05). 
Finally, ME children had 4.5 times the odds of comparison children to have a total difficulties 
score within the clinical range (41.4% vs. 13.6%; p < .0001). 
 
Table 7 
SDQ Clinical Range Cut-off Scores for ME and Comparison Children at Age 4.5 Years 
No. of Children in SDQ 
Clinical Range 
ME 
(n = 87) 
(%) 
Comparison 












27.6 10.7 8.97 3.19 (1.46- 6.97) .003 
Emotional Problems  
 
18.4 8.7 3.85 2.35 (.98- 5.63) .05 
Peer Problems  
 
23.0 10.7 5.23 2.50 (1.12- 5.56) .02 
Prosocial Behaviour 
 
21.8 6.8 9.04 3.83 (1.53- 9.62) .003 
Total Difficulties 41.4 13.6 18.78 4.49 (2.21- 9.1) <.0001 
 
3.3  Risks of Early-Onset Psychiatric Disorders  
Across each disorder category (i.e. externalising, internalising, and other disorders) 
rates of individual disorders were computed and then the overall “any” category rates were 






type, ADHD Hyperactive-Impulsive type, ADHD Combined type) and Conduct/Oppositional 
Disorders (CD and ODD) were included. Rates of all ADHD subtypes were summed to create 
an “Any ADHD” category. Rates of both CD and ODD were combined to create an “Any 
Conduct/Oppositional” category. Within the Internalising/Other Disorder category, individual 
anxiety disorder and individual depressive disorder rates were computed, as well as the overall 
“any anxiety disorder” and “any emotional disorder” rates. Additionally, the rate of any 
disorder diagnosis was computed. Odds ratios (OR) with confidence intervals (CI) are reported 
for each of the composite variable “any” disorder diagnoses to provide a measure of effect size. 
The reporting of OR was confined to these summary measures since there were insufficient 
cases for the singular diagnosis variables to generate these. 
3.3.1  Rates of Early-Onset Externalising Disorders 
Table 8 reports the rates of externalising behaviour disorders in ME and comparison 
children at age 4.5 years. With respect to Attention Deficit Hyperactivity Disorder, ME 
children were subject to significantly higher rates of ADHD Combined (9.2% vs. 1.9%; p = 
.026) and any diagnosis of ADHD (14.9% vs. 1.9%; p = .001). Methadone-exposed children 
had almost nine times the odds of being diagnosed with any ADHD compared to comparison 
children. However, there were no significant differences between both groups of children on 
rates of ADHD Inattentive type (p = .12) and ADHD Hyperactive-Impulsive type (p = .06).  
Similarly, between group differences were also observed for rates of Conduct and 
Oppositional disorders. Children in the ME group were subject to significantly higher rates of 
CD diagnoses (8% vs. 0%; p = .003), ODD diagnoses (14.9% vs. 1%; p < .0001), and any 
Conduct/Oppositional Diagnosis (19.5% vs. 1%; p < .0001). Methadone-exposed children had 
almost 25 times the odds of comparison children of receiving a diagnosis of 
Conduct/Oppositional Disorder. An “any externalising disorder” composite variable was 






Impulsive, ODD and CD. Approximately 24% of ME children were diagnosed with an 
externalising disorder compared to 1.9% of non-exposed comparison children (p < .0001). 
Furthermore, the odds of ME children in being diagnosed with any externalising disorder were 
approximately 16 times that of the comparison group of children.  
 
Table 8 
Rates of DSM-IV Externalising Diagnoses as Assessed by the DAWBA for ME and Comparison 




(n = 87)  
(%) 
Comparison 
(n = 103) 
 (%) 





     
Inattentive 2.3 0.0 2.39 - .12 
Hyperactive-Impulsive 3.4 0.0 3.61 - .06 
Combined 9.2 1.9 4.98 - .03 




     




14.9 1.0 13.49 - <.0001 














3.3.2  Rates of Early-Onset Internalising Disorders and ASD 
Table 9 presents the rates of emotional and other disorder diagnoses for ME and 






groups was Separation Anxiety Disorder (SAD), which was significantly higher in the ME 
group compared to the comparison group (11.5% vs. 2.9%; p = .02).  In contrast to the findings 
above on externalising disorders, whilst rates of emotional disorders were somewhat elevated 
in the ME group, no other conditions met the statistical significance threshold. Finally, no 
children in either group were diagnosed with Pervasive Developmental Delay/Autism.  
Taken together, the results presented in Table 9 suggest ME children at age 4.5 are not 
at an increased risk of an internalising disorder diagnosis or an “other” disorder diagnosis, such 
as Pervasive Developmental Delay/Autism. Finally, the rates of a diagnosis of any psychiatric 
disorder for ME and comparison children was investigated. Methadone-exposed children had 
4.4 times the odds of being diagnosed with any disorder compared to comparison children (p 
< .0001), which suggests that ME children are at an increased risk of being diagnosed with a 
psychiatric disorder in general.  
 
Table 9  
Rates of DSM-IV Internalising and Other Disorder Diagnoses as Assessed by the DAWBA for 
ME and Comparison Children at Age 4.5 Years 
DAWBA Internalising and 
Other Diagnoses 
ME 
(n = 87) 
(%) 
Comparison 
(n = 103) 
(%) 
χ2 Odds Ratio (95% CI) p 
Anxiety Disorders      
Separation Anxiety 11.5 2.9 5.45 - .02 
Specific Phobia 6.9 1.9 2.87 - .09 
Social Phobia 1.1 1.9 0.19 - .66 
Generalised Anxiety 1.1 2.9 0.71 - .40 
Any Anxiety Disorder 14.9 8.7 1.77 1.84 (0.74- 4.53) .18 







3.4  Rates and Patterns of Comorbid Mental Health Disorders 
Table 10 shows the proportion of children in each group who were subject to no, one, 
two or three disorder diagnoses. For this analysis, children meeting the criteria of any of the 
major disorder categories (i.e., Any ADHD) were coded as subject to problems in that disorder 
domain. Diagnoses included in this table include CD, ODD, any ADHD and any internalising 
disorder. As shown, ME children were more likely to be diagnosed with multiple co-occurring 
disorders compared to non-exposed comparison children (p < .0001).  For both the ME and 
comparison group, a majority of children did not meet DSM-IV criteria for CD, ODD, ADHD, 
or an emotional disorder (65.5% & 89.3%, respectively).  However, 18.4% of ME children had 
one diagnosis of any of these disorders and 9.7% of comparison children had one diagnosis. 
Only one child in the comparison group met criteria for two comorbid disorders. 
Approximately 14% of ME children had two of these diagnoses, and 2.3% ME children met 
criteria for three. Given the elevated rates of comorbid mental health disorders in the ME group 
of children, the nature of these comorbidities was further examined. This analysis was confined 




Major Depression  1.1 0.0 1.19 - .28 
Any Internalising Disorder  14.9 8.7 1.77 1.84 (0.74- 4.53) .18 
Other Disorders      
PDD/Autism 0.0 0.0 - - - 







Frequencies of Comorbid DAWBA Diagnoses in ME and Comparison Children at 








Note: χ2 = 19.61 (3); p < .0001.  
 
Given the elevated rates of comorbid mental health disorders in the ME group, Figure 
3 shows the pattern of co-occurring psychiatric disorders in ME children at age 4.5. 
Frequencies represent the children who were diagnosed with at least one disorder. Disorders 
included in this analysis included Conduct Disorder, Oppositional Defiant Disorder, ADHD 
(any) and any internalising disorder.  
ADHD and ODD had the highest comorbidity rate, with four ME children meeting 
criteria for both disorders at 4.5 years (4.6%). More ME children had comorbid ADHD and 
ODD than ADHD or ODD alone (3.5% & 3.5%, respectively). ADHD and any internalising 
disorder had a comorbidity rate of 1.1%, with only one child meeting criteria for both of these 
disorders. Three ME children met criteria for both ADHD and CD (3.5%). Three children also 
met criteria for ODD and an internalising disorder (3.5%). One child met criteria for CD and 
ODD (1.1%). Lastly, two children met criteria for ADHD, CD, and ODD (2.3%). These results 
reflect the variability of diagnostic comorbidity patterns for preschool children prenatally 
exposed to methadone.  
         
No. of Diagnoses ME (n = 87) (N)                  (%) 
Comparison (n =103)  
        (N)                  (%) 
0 57 65.5 92 89.3 
1 16 18.4 10 9.7 
2 12 13.8 1 1.0 















     Figure 3 














3.5  Associations Between Prenatal Methadone Exposure and Mental Health Outcome After  
Covariate Adjustment 
The above results suggest that ME children were at an increased risk of behavioural 
and emotional maladjustment on parent-report measures, as well as an elevated risk of meeting 
diagnostic criteria for externalising disorders at 4.5 years old, compared to comparison 
children. In contrast, ME children were not at an increased risk of meeting diagnostic criteria 
for internalising disorders at 4.5 years.  
However, a further important question that needs to be addressed is the extent to which 
these elevated rates of mental health disorders reflect the direct effects of methadone, or might 













dependence and need for MMT. The following subsection explores the influence of 
confounding factors that could contribute to the higher rates of externalising behaviour disorder 
found in ME children at age 4.5 years. Internalising disorder diagnoses were not included in 
this analysis because of the low rates of these diagnoses and because no major significant 
differences were found. A binary logistic regression was conducted in order to determine the 
independent contributions of group status (ME or comparison), sex, birth weight, social risk, 
maternal nutrition, maternal mental illness during pregnancy, and poly-substance use to 
externalising behaviour diagnoses at 4.5 years old. These variables were all included in the 
analysis due to significant correlations with methadone maintenance group status in the present 
study and previous research. Within the covariate adjustment analysis, B refers to the values 
predicting the dependent variable from the independent variable and SE refers to the standard 
error of the coefficients. The purpose of this analysis was to investigate whether the 
relationship between group status and the externalising disorder outcome variables remained 
significant after including multiple infant and maternal psychosocial variables. Each of the 
major disorder outcomes that were found to be significant in the above bivariate analyses were 
examined individually and results were as follows. 
Table 11 presents the results from the logistic regression analysis of the any ADHD 
outcome variable, which resulted in social risk being the only significant covariate of any 
ADHD diagnosis at age 4.5 years in the second model (p = .03). In the third model for Table 
11, social risk remained the only variable significantly associated with ADHD (p = .03). Model 
4 introduced maternal mental illness and poly-substance use during pregnancy into the model, 
which did not result in any significant covariates for any ADHD diagnosis. Social risk 
approached significance (p = .07), but was no longer significantly associated with ADHD at 
age 4.5. Group status was not significantly associated with ADHD in preschool aged children 







Hierarchical Logistic Regression Analysis of Covariates Associated with Any ADHD in ME 
Children at Age 4.5 Years  
Note: Outcome variable; No= 0, Yes= 1.  
Variables Associated 
with ADHD 
B (SE) Odds Ratio 
(95% CI) 
p 
Model 1    
Group Status -2.19 (0.78) 0.11 (0.03-0.51) .01 
Model 2    
Group Status -1.01 (0.84) 0.37 (0.07-1.91) .23 
Child Sex -1.09 (0.64) 0.34 (0.10-1.18) .09 
Birth Weight -0.00 (0.00) 1.00 (1.00-1.00) .12 
Social Risk 0.61 (0.28) 1.83 (1.06-3.16) .03 
Model 3    
Group Status -0.93 (0.97) 0.39 (0.06-2.61) .33 
Child Sex -1.08 (0.64) 0.34 (0.10-1.19) .09 
Birth Weight -0.00 (0.00) 1.00 (1.00-1.00) .12 
Social Risk 0.60 (0.28) 1.83 (1.06-3.16) .03 
Maternal Nutrition -0.00 (0.01) 0.10 (0.97-1.03) .87 
Model 4    
Group Status -0.47 (1.03) 0.63 (0.08-4.69) .65 
Child Sex -1.14 (0.65) 0.32 (0.09-1.14) .08 
Birth Weight -0.00 (0.00) 1.00 (1.00-1.00) .29 
Social Risk 0.54 (0.30) 1.72 (0.96-3.09) .07 
Maternal Nutrition -0.00 (0.02) 1.00 (0.97-1.03) .95 
Maternal Mental Illness 1.09 (0.67) 2.97 (0.80-11.01) .10 







Table 12 presents the logistic regression results for any diagnosis of Conduct Disorder 
and/or Oppositional Defiant Disorder at age 4.5 years. Model 2 for Table 12 resulted in group 
status being significantly associated with any CD/ODD (p = .04). Social risk approached 
significance (p = .05). After introducing maternal nutrition in Model 3, group status remained 
significantly associated with any CD/ODD (p = .02). In the final model for Table 12, which 
included maternal mental illness and poly-substance use, group status remained significantly 
associated with CD/ODD (p = .02). Again, social risk approached significance but was not  
significantly associated with a diagnosis of CD/ODD at age 4.5 years (p = .05). This suggests 
that after controlling for various confounding factors, methadone exposure in-utero is the only 
significant predictor of a diagnosis of CD/ODD in preschool aged children, independent of 




Hierarchical Logistic Regression Analysis of Covariates Associated with Any CD/ODD  in ME 
Children at Age 4.5 Years  
Variables Associated with 
CD/ODD 
B (SE) Odds Ratio 
(95% CI) 
p 
Model 1    
Group Status -3.14 (1.04) 0.04 (0.01-0.33) .00 
Model 2    
Group Status -2.28 (1.11) 0.10 (0.01-0.90) .04 
Child Sex -0.83 (0.59) 0.44 (0.14-1.39) .16 
Birth Weight 0.00 (0.00) 1.00 (1.00-1.00) .48 
Social Risk 0.45 (0.28) 1.56 (0.90-2.70) .11 
Model 3    






Note: Outcome variable; 0= No, 1= Yes 
 
 The rates of a diagnosis of any externalising disorder at age 4.5 years are presented in 
Table 13. Group status remained a significant predictor of any externalising disorder diagnoses 
for the first three models, but was no longer significant when maternal psychopathology during 
pregnancy and poly-drug use were included in the model (p = .07). After including all potential 
covariates in the equation, no variable remained a significant predictor of an externalising 






Child Sex -0.89 (0.60) 0.41 (0.13-1.33) .14 
Birth Weight 0.00 (0.00) 1.00 (1.00-1.00) .50 
Social Risk 0.49 (0.28) 1.63 (0.95-2.80) .08 
Maternal Nutrition 0.01 (0.01) 1.01 (0.99-1.04) .27 
Model 4    
Group Status -2.94 (1.24) 0.05 (0.01-0.60) .02 
Child Sex -0.89 (0.60) 0.41 (0.13-1.35) .14 
Birth Weight 0.00 (0.00) 1.00 (1.00-1.00) .59 
Social Risk 0.58 (0.30) 1.78 (1.00-3.18) .05 
Maternal Nutrition 0.01 (0.01) 1.01 (0.99-1.04) .35 
Maternal Mental Illness 0.49 (0.60) 1.63 (0.50-5.31) .41 







Hierarchical Logistic Regression Analysis of Covariates Associated with Any Externalising 
Disorder in ME Children at Age 4.5 Years  
Note: Outcome variable; 0=No, 1=Yes 
Variables Associated with 
Externalising Diagnoses B (SE) 
Odds Ratio 
(95% CI) p 
Model 1    
Group Status -2.72 (0.76) 0.07 (0.02-0.29) .00 
Model 2    
Group Status -1.80 (0.82) 0.17 (0.03-0.83) .03 
Child Sex -0.77 (0.52) 0.47 (0.17-1.30) .14 
Birth Weight -0.00 (0.00) 1.00 (1.00-1.00) .31 
Social Risk 0.49 (0.24) 1.62 (1.01-2.61) .05 
Model 3    
Group Status -2.06 (0.91) 0.13 (0.02-0.77) .02 
Child Sex -0.80 (0.53) 0.45 (0.16-1.27) .13 
Birth Weight -0.00 (0.00) 1.00 (1.00-1.00) .31 
Social Risk 0.50 (0.24) 1.65 (1.03-2.64) .04 
Maternal Nutrition 0.01 (0.01) 1.01 (0.99-1.03) .50 
Model 4    
Group Status -1.76 (0.96) 0.17 (0.03-1.12) .07 
Child Sex -0.85 (0.53) 0.42 (0.15-1.22) .11 
Birth Weight 0.00 (0.00) 1.00 (1.00-1.00) .54 
Social Risk 0.47 (0.25) 1.61 (0.98-2.64) .06 
Maternal Nutrition 0.01 (0.01) 1.01 (0.99-1.03) .51 
Maternal Mental Illness 0.80 (0.55) 2.22 (0.76-6.49) .15 








Children born to opioid-dependent mothers treated with methadone during pregnancy 
are widely recognised to be an especially vulnerable group, given their likely exposure to a 
wide range of risk factors that can contribute to adverse developmental outcomes. Previous 
studies have identified heightened levels of behavioural issues in methadone-exposed children 
compared to non-exposed comparison children, such as aggression, hyperactivity, 
inattentiveness and lack of prosocial behaviour. However, findings on internalising difficulties 
in ME children are limited. This prospective, longitudinal study extended on existing research 
by examining the extent to which ME children were at risk of early-onset externalising and 
internalising problems and disorders at age 4.5 years old, compared to comparison children of 
the same age. Specifically, this study compared children’s behavioural and emotional 
adjustment on the SDQ and risk of psychiatric disorder assessed using the DAWBA, which is 
a psychometrically valid diagnostic interview completed with a child’s primary caregiver. 
Studies in this area to date have typically relied on parent-report screening measures and few 
have considered the influence of potential confounding factors such as social risk and maternal 
poly-drug use during pregnancy. They have also tended to have high sample attrition and poor 
measurement of maternal drug use during pregnancy. This study addressed these 
methodological issues and utilised an objective measure of psychiatric diagnoses in both ME 
and comparison children at age 4.5 years old as well as the caregiver-reported SDQ.  
 As hypothesised, the findings from this study showed that children born to mothers 
maintained on methadone during pregnancy had heightened levels of behavioural and 
emotional adjustment difficulties and were more at risk of meeting DSM-IV diagnostic criteria 
for a psychiatric disorder. Specifically, ME children were significantly more likely to meet 






Disorder, Oppositional Defiant Disorder and Conduct Disorder. However, there were no 
significant between-group differences in internalising disorder risk. Additionally, ME children 
were significantly more likely to be diagnosed with comorbid externalising and internalising 
disorders. Even after taking into account other social risk and pregnancy factors, methadone 
exposure during pregnancy placed children at an increased risk of a diagnosis of ODD/CD. 
Major findings are discussed below in relation to each of the study aims.  
4.1  Behavioural and Emotional Adjustment 
The first aim of this thesis was to investigate the behavioural and emotional adjustment 
of ME and comparison children on the parent-reported Strengths and Difficulties 
Questionnaire. This screening measure includes five subscales measuring conduct problems, 
hyperactivity/inattention, emotional symptoms, peer problems and prosocial behaviour, and 
provides a total difficulties score and an additional impact supplement which evaluates the 
distress and impairment associated with the child’s difficulties (Goodman & Scott, 1999). 
Scores on all subscales resulted in statistically significant differences between ME and 
comparison children. The conduct and hyperactivity/inattention subscales resulted in the 
largest mean differences. These findings support the first hypothesis made; mothers maintained 
on methadone during pregnancy reported heightened levels of behavioural adjustment 
difficulties such as conduct problems and hyperactivity/inattention in their preschool-aged 
children. This is consistent with other studies which have also reported increased levels of 
conduct problems and hyperactivity/inattention in opioid-exposed children (de Cubas & Field, 
1993; Sandtorv et al., 2018; Sundelin-Wahlsten & Sarman, 2013). As hypothesised, ME 
children were also found to have significantly higher levels of emotional symptoms than non-
exposed children. Compared to behavioural difficulties, emotional difficulties in ME preschool 






reported higher levels of depressive symptoms in opioid-exposed children. de Cubas and Field 
(1993) also reported heightened levels of anxiety in ME children. Lastly, ME children had 
significantly higher levels of peer problems and scored significantly lower than comparison 
children in prosocial behaviour. This suggests that ME children may experience increased 
difficulty with their social skills. Other studies have also reported significant difficulties with 
social adjustment in opioid-exposed children (de Cubas & Field, 1993; Hunt et al., 2008; 
Soepatmi, 1994; van Baar et al., 1994). The results from the current study in addition to 
previous research highlight the adjustment difficulties in multiple domains ME children may 
be subject to. 
The findings from the administration of the SDQ mirror other studies that have utilised 
parent-report measures to assess behavioural and emotional adjustment. Previous studies have 
reported that methadone-exposed children to have significantly higher scores on the parent-
report Child Behavior Checklist (CBCL) compared to non-exposed children (de Cubas & Field, 
1993; Nygaard et al., 2016; Soepatmi, 1994), which also measures caregiver-reported 
behavioural and emotional difficulties in children. For example, Ornoy et al. (2001) found that 
children born to mothers addicted to heroin during pregnancy had the highest externalising 
behaviour scores on the CBCL compared to control children. However, other studies have 
found conflicting results. For example, Sundelin-Wahlsten and Sarman (2013) administered 
the SDQ to parents of buprenorphine-exposed children and found no significant problems on 
any of the five scales. Although, this study did not include a matched control group and the 
children were exposed to buprenorphine, not methadone. Speculatively, buprenorphine 
exposure in-utero may not have the same effect on long-term behavioural and emotional 
development in comparison to methadone and other opioids.  
Further examination of the extent to which children’s scores were in the high-risk range 






conduct problems compared to 10.7% of comparison children (OR = 6.2). Relatedly, ME 
children also had approximately 3 times the odds of comparison children to obtain 
hyperactivity/inattention scores within the clinical cut-off range, with just over a quarter of ME 
children scoring above the 90th percentile. Methadone-exposed children were not significantly 
more likely to obtain emotional symptom scores within the clinical cut-off range. Multiple 
studies examined the rates of clinically significant hyperactivity, inattention and impulsivity in 
opioid-exposed children using parent-report measures. Ornoy et al. (2001) reported a 
significantly higher proportion of school-age heroin-exposed children having clinically 
significant inattention, hyperactivity and impulsivity compared to controls, with 54% of 
children born to heroin-dependent mothers raised at home obtaining scores above the clinical 
cut-off point on the Conners questionnaire. Approximately one quarter of adopted heroin-
exposed children and children born to heroin-dependent fathers obtained clinically significant 
scores. Similarly, as reported by Nygaard et al. (2016), one-quarter of opiate-exposed children 
had clinically significant caregiver-reported ADHD-related symptoms on the ADHD Rating 
Scale, compared to no comparison children. These findings by Nygaard et al. are similar to the 
present study, as approximately one-quarter of opioid-exposed children had clinically 
significant hyperactivity, inattention and impulsivity in both studies. However, in the present 
study, no further analyses were done that explored the contribution of potential confounders. 
Due to this, it cannot be determined whether the results are solely due to methadone exposure 
during pregnancy or if birth, maternal and/or socio-familial factors also contribute to the 
children’s scores.  
4.2  DAWBA Externalising and Internalising Disorder Diagnoses 
The current study also sought to investigate the risk of meeting diagnostic criteria for 






Further between-group differences in mental health disorder diagnoses were explored using 
the DAWBA, which provided computer-generated psychiatric diagnoses for the children. The 
results from the DAWBA were the primary focus of this thesis, as studies on psychiatric 
diagnoses of opioid-exposed preschool-aged children is a highly under-researched area. 
Consistent with results from the SDQ, ME children were significantly more likely to be 
diagnosed with an externalising behaviour disorder. However overall, relative to their same 
age non-exposed peers, ME children were not at an increased risk of developing an 
internalising disorder.  
4.2.1  Conduct Disorder and Oppositional Defiant Disorder 
Between-group differences in diagnoses of Conduct/Oppositional Defiant Disorder 
diagnoses were examined on the DAWBA. Children in the ME group were significantly more 
likely to meet criteria for a diagnosis of ODD, CD and CD/ODD. Approximately 15% of ME 
children were diagnosed with ODD, compared to 1% of comparison children. Conduct 
Disorder was less prevalent, with 8% of ME children diagnosed with CD, compared to no 
comparison children. Methadone-exposed children had almost 25 times the odds of being 
diagnosed with any CD and/or ODD compared to comparison children at age 4.5 years (19.5% 
vs. 1%).   
The contributions of confounding factors to a diagnosis of CD/ODD at age 4.5 years 
were also investigated. After controlling for child sex, birth weight, social risk, maternal 
nutrition, maternal psychopathology and poly-substance use, group status remained the only 
significant predictor of CD/ODD (p = .02). This suggests that ME children are at an increased 
risk of developing CD or ODD at age 4.5 years old, even after taking into account other known 
maternal, clinical and social factors measured during the perinatal period that may play a role 
in the development of these disorders.  This raises questions about the teratogenic mechanisms 






Additionally, the potential impact of adverse postnatal experiences and trauma may also 
contribute to the rates of CD/ODD observed in ME children. Although the current study did 
not examine the impact of postnatal factors on psychiatric outcome, contextual family factors 
such as parenting practices, parental mental illness and marital conflict are associated with 
conduct and antisocial behaviour in children (Matthys & Lochman, 2017), with parenting 
behaviours functioning as a major key influence on child behaviour difficulties (Burke et al., 
2002). Therefore, a potential avenue for future research could be to examine the postnatal 
factors that may increase the likelihood of ME children meeting diagnostic criteria for early-
onset CD.  
The significant association between prenatal methadone exposure and ODD/CD in the 
present study is consistent with an earlier study, which showed that opioid-exposed children in 
the first six years of life were significantly more likely to have a diagnosis of CD than non-
exposed children (Azuine et al., 2019). Interestingly, opioid exposure was not as strongly 
associated with CD in children older than six years, which suggested a differential risk over 
the life course. This may also reflect changes in family circumstances over time as many of 
these children are often adopted or placed in care as they grow up.  
Despite the low base rate of CD in preschool-age children, the prevalence of this 
disorder in this age range is concerning and emphasises the vulnerable nature of this 
population. Additionally, given the young age of the children studied, the present findings may 
not reflect the true rates of CD in ME children. Nock, Kazdin, Hiripi, and Kessler (2006) 
conducted a retrospective assessment of CD using DSM-IV criteria in a representative sample 
of US adults and reported a median age of onset of approximately 11 ½ years old. However, 
the age of onset ranged widely within individuals and the retrospective nature of the study may 
have resulted in participants forgetting events and/or the timing of them (Nock et al., 2006). 






childhood years. In this study, 8% of ME children were diagnosed with CD. As children get 
older and their environment grows in complexity, the prevalence of CD in ME children may 
increase or depending on their developmental trajectory, decrease. Additionally, since ODD 
often precedes CD, the high prevalence rate of early-onset ODD may subsequently lead to 
increased risk of later diagnoses of childhood-onset CD.  
4.2.2  Attention-Deficit Hyperactivity Disorder  
Methadone-exposed children had almost 9 times the odds of being diagnosed with any 
type of ADHD compared to comparison children. Specifically, ME children were significantly 
more likely to meet DSM-IV diagnostic criteria for ADHD Combined type (9.2% vs. 1.9%). 
However, there were no significant between-group differences in the rates of children meeting 
diagnostic criteria for ADHD Hyperactive-Impulsive type and ADHD Inattentive type.  
The relationship between methadone exposure and an ADHD diagnosis at age 4.5 years 
was further examined by investigating the contributions of various confounding variables 
measured during the perinatal period. Results showed that after controlling for child sex, birth 
weight, social risk, maternal nutrition, maternal mental illness during pregnancy and poly-
substance use during pregnancy, between-group differences in the risk of ADHD were reduced 
to non-significance (p = .65). These results suggest that ADHD does not reflect the teratogenic 
effects of methadone in-utero but rather likely reflects the effects of other adverse exposures 
correlated with maternal methadone treatment.  
These results are somewhat similar to findings from a study by Ornoy et al. (2001), 
who found that children exposed to opioids prenatally who had been adopted and were no 
longer living with their biological mother had significantly lower rates of ADHD symptoms 
compared to opioid-exposed children who were still living with their biological mother. 
Findings from Ornoy et al. (2001) suggest that the environment the child is raised in is an 






present study, the children participating in the study by Ornoy et al. were of school age, which 
may be why elevated levels of clinically significant hyperactivity, inattention and impulsivity 
were observed. According to DSM-5 diagnostic criteria for ADHD, several Hyperactive-
Impulsive or Inattentive symptoms must occur in two or more settings (American Psychiatric 
Association, 2013). Therefore, once children reach school age, prevalence rates of ADHD in 
ME children may be increased as this is when attentional difficulties are most often detected, 
given that children are expected to sit at a desk for increased periods and pay attention during 
class. A child who is unable to sustain their attention and regulate their behaviour may struggle 
to complete their work, which may result in classroom disruption. This is further supported by 
the findings by Azuine et al. (2019), who found that opioid exposure was associated with an 
increased risk of ADHD in school-aged children compared to preschool-aged children. This 
may be why prenatal methadone exposure was not significantly associated with any diagnosis 
of ADHD at 4.5 years in the present study, as the presentation of ADHD may vary according 
to the child’s stage of development. Therefore, further longitudinal follow-up of these children 
will be important.  
4.2.3  Rates of Any Externalising Disorder 
A composite variable consisting of ADHD, CD and ODD diagnoses was summed to 
create an “Any Externalising Disorder” variable. Approximately one-quarter of ME children 
were diagnosed with any externalising disorder, compared to only 1.9% of comparison 
children. However, after controlling for child sex, birth weight, social risk, maternal nutrition, 
maternal mental illness during pregnancy, and poly-substance use during pregnancy, 
significance attenuated and the difference was no longer statistically significant. This could be 
due to the influence of ADHD included in the composite variable. These results suggest that 






mechanisms are complex, reflecting the effects of maternal poly-drug use and other adverse 
prenatal exposures.  
4.2.4  Internalising and Other Disorders 
This study also examined children’s risks for a range of internalising disorders, 
including Anxiety and Depressive Disorders. There were no significant differences in any 
internalising disorder diagnoses except for rates of Separation Anxiety Disorder (SAD). 
Methadone-exposed children scored significantly higher for rates of SAD, however, no further 
analyses were made to explore the effects of potential confounding variables. Therefore, this 
finding should be interpreted with caution. Regardless, SAD in young children is 
developmentally normative so this may explain the elevated rates of this disorder. Given the 
high-risk familial circumstances, maternal mental health difficulties and parental changes 
children exposed to methadone in-utero are likely to experience, this may result in an increased 
risk of developing SAD. In the same cohort of children as the present study, Lean, Prichard 
and Woodward (2013) reported that 44% of children born to mothers maintained on methadone 
during pregnancy had been removed from the custody of their biological mother by the time 
they turned 4.5 years old. Speculatively, this early-onset environmental and familial instability 
may contribute to the elevated rates of SAD in ME children. The association between prenatal 
methadone exposure and SAD in young children and the contribution of environmental risk 
factors is a potential avenue for future research.  
 These findings from the DAWBA aligned with the results obtained from the SDQ 
screening measure clinical cut-off points. Thus, taken together, the findings from the SDQ and 
DAWBA suggest that ME children do not, at least at this early age, appear to be at an increased 
risk of developing an internalising disorder. However, some caution is needed in the 
interpretation of these results, given the young age of the children studied and the fact that 






diagnosed with any internalising disorder compared to 8.7% of comparison children. It is 
therefore possible that with increasing age, ME children may still be at risk. Subclinical 
internalising difficulties may eventuate into clinical disorder later in childhood. Another 
possible explanation is that children may manifest emotional difficulties as externalising 
behaviour problems. Alternatively, sometimes internalising disorders can be missed in young 
children who may not be able to verbally express negative emotions they are experiencing.  
The current study also assessed the rates of Autism Spectrum Disorder (ASD) in ME 
and comparison children, as it is a developmental disorder that often emerges early. However, 
no children from either group met diagnostic criteria for ASD. Since ASD has a low base rate 
in the general population, it is necessary to have a larger sample size. The present study would 
be too underpowered to adequately examine the rates of ASD in ME children. Future research, 
ideally involving a larger sample is potentially warranted as Sandtorv et al. (2018) reported 
increased symptoms associated with ASD in opioid-exposed children aged approximately ten 
years old.  
 
4.2.5  Comorbid DAWBA Disorders  
As expected, results revealed high rates of diagnostic comorbidity in ME compared to 
comparison children. Methadone-exposed children had significantly higher rates of 
comorbidity compared to comparison children. One comparison child met diagnostic criteria 
for two psychiatric disorders at age 4.5, whereas 14 ME children met criteria for two or more 
psychiatric disorders. Three children met criteria for a single diagnosis of ADHD, however, 
ten children met criteria for ADHD and either ODD, CD, or an emotional disorder. Similarly, 
only three children met criteria for a single diagnosis of ODD. In contrast, nine children met 
criteria for an emotional disorder and four children met criteria for an emotional disorder and 






children meeting criteria for both of these disorders. Although ODD often functions as a 
precursor for CD, children meeting criteria for both ODD and CD may suggest these children 
exhibited oppositionality as well as more severe conduct behaviours. Therefore, the presence 
of ODD and CD in  ME preschool children can function as an indication of severity. To date, 
no other studies have explored co-occurring psychiatric disorders in ME preschool children. 
Therefore, although comorbid mental health disorders in ME children were not explored 
extensively, the findings of the current study suggest a need for further research surrounding 
this issue. Studies have noted high comorbidity rates, suggesting approximately 54 -84% of 
children and adolescents with a diagnosis of ADHD may also meet diagnostic criteria for ODD 
and are at risk of developing CD (Pliszka, 2007). In the present study, approximately 77% of 
ME children who met criteria for ADHD also met criteria for another mental health disorder. 
These results suggest that children exposed to methadone during pregnancy are at an increased 
risk of meeting diagnostic criteria for more than one mental health disorder compared to non-
exposed peers, further highlighting the clinical complexity of these children.   
4.2.6  Issues with Diagnosing Psychiatric Disorders in Preschool  
Egger and Angold (2006) note several concerns associated with the identification and 
classification of different forms of psychopathology in preschool children. These concerns 
include the difficulty associated with accurately assessing symptoms due to the rapid 
development in multiple domains, lack of consideration of developmental variation in 
dominant classification systems, risk of labelling children with diagnoses that alter perceptions 
of the child, and individual differences in the child that may be mistakenly attributed to 
psychopathology (Egger & Angold, 2006). Additionally, some existing psychiatric measures 
may not be designed to appropriately distinguish between developmentally normative 
behaviour in preschool-aged children and psychopathology (Bufferd, Dougherty, Carlson, 






effectively assess externalising and internalising difficulties and disorders in children from 
preschool to adolescence, it should be acknowledged that the children in this study were at the 
lower end of the normative age range. Keenan and Wakschlag (2002) reviewed the evidence 
on the consideration of preschool behavioural problems within a diagnostic framework and 
concluded that typical and atypical behaviour problems can be distinguished in early childhood 
and the DSM can be applied effectively to identify impairing disruptive behaviours (Keenan 
& Wakschlag, 2002). However, more research is required to understand the clinical 
implications of early-onset diagnoses of childhood mental health disorders and effective 
treatments for these conditions.   
4.3  Additional Issues and Implications of Findings  
  
Although postnatal factors that might contribute to ME children’s mental health 
difficulties at age 4.5 were not examined in this thesis, these factors likely also play an 
important role in placing ME children at increased mental health risk. For example, factors 
such as parenting behaviours, parental mental health difficulties, familial and environmental 
instability could influence children’s mental health outcome. Given many of the mothers 
maintained on methadone during pregnancy have additional psychosocial challenges, the 
effects of postnatal trauma could be relevant to the ME population of children. These maternal 
psychosocial challenges may expose the child to more risk factors that can influence the 
likelihood of externalising and internalising disorders.  
The significant mental health difficulties in a young population of children also raise 
concerns about the academic outcomes of ME children.  Since the children had not yet reached 
school age, any potential academic difficulties were unknown in the present study. However, 
in a prospective longitudinal study on the same cohort of children at 9.5 years old, ME children 






expected levels of achievement (Lee, Woodward, & Henderson, 2019). However, the learning 
difficulties of opioid-exposed children remain relatively under-studied compared to other 
neurodevelopmental outcomes. Children prenatally exposed to methadone have been found to 
have significant behavioural issues which are likely to persist through to school age (given 
their high-risk contexts). Speculatively, disruptive behaviour which interferes with teaching 
and the child’s learning may contribute to lower educational achievement. Therefore, 
specialised support could be beneficial for methadone-exposed children’s behavioural and 
emotional adjustment during the transition into primary school to promote academic success 
and social adjustment.  
Overall, these findings highlight the importance of timely early intervention for 
children born to mothers maintained on methadone to help treat externalising behaviour 
disorders and prevent the development of further internalising and externalising difficulties. 
The increased likelihood of methadone-exposed children to experience multiple mental health 
difficulties increases the risk of an even poorer long-term outcome. Therefore, it is of critical 
importance that these children receive early intervention. Early intervention approaches such 
as family-focused interventions can help reduce symptoms of mental health difficulties in 
young children and impairment associated with these difficulties (Gleason, Goldson, & 
Yogman, 2016). These findings also bring attention to the importance of psychosocial support 
for the mothers and families of children exposed to methadone in-utero. As discussed, mothers 
maintained on methadone are significantly more likely to experience high levels of social risk, 
poly-substance use and mental illness. Therefore, targeted social support should be given to 
mothers participating in methadone maintenance treatment to reduce the number of risk factors 
the children are exposed to. Since these maternal and social risk factors can accentuate the 






services for pregnant women maintained on methadone in combination with early intervention 
for children may help to avert these developmental risks.  
4.4  Strengths and Limitations of the Current Study 
4.4.1  Strengths  
The present study sought to address many of the limitations of previous studies. First, 
as discussed in Chapter 1, a major issue that is often inherent to drug outcome studies are the 
high rates of attrition. In the current study, 81% of the identified ME children completed the 
4.5-year assessment and 90% of the identified comparison children completed the 4.5-year 
assessment. Although participants were still lost at follow-up, retention rates remained high, 
helping to maximise the representativeness of the sample and generalisability of study findings 
to ME and non-exposed preschoolers in New Zealand.  
Second, the present study utilised random maternal urine samples during pregnancy 
and analysis of infant meconium to assess maternal drug use. Maternal self-report of drug use 
during pregnancy was also assessed. This is a strength of the study as a vast amount of previous 
research measured maternal poly-drug use during pregnancy using only maternal self-report, 
which can be prone to under-reporting. As well as detecting the presence of substance use 
during pregnancy, toxicology analysis can also help determine the type of substances used.  
Third, a significant strength of the current study included the objective measure of 
diagnosable disorders in ME children. To date, no other study on ME children has generated 
mental health diagnoses for preschoolers using a structured parent interview. Provisional 
diagnoses were accepted or rejected by a clinician, generating a definitive diagnosis. This 
clinician was also blind to the children’s study group. The use of the SDQ in addition to the 
DAWBA is also a strength in the present study, providing a parent-report account of 






Finally, the present study controlled for various confounding factors that may also 
contribute to externalising disorder diagnoses in preschool children. Many previous studies did 
not adequately control for confounding factors, therefore making it difficult to assess the 
independent effects of opioid-exposure on child outcomes. The present study controlled for 
poly-drug use, whereas no previous studies did. This is a significant strength since various 
substances have also been found to have neurodevelopmental effects in-utero, such as cannabis 
and alcohol (Williams & Ross, 2007).  
4.4.2  Limitations  
Like virtually all studies on children exposed to substances in-utero, this study is subject 
to methodological limitations. One limitation of this study was the use of parent-report 
measures (SDQ) to assess the children’s behaviour problems. A major issue that can arise 
during the use of parent-report measures is parental response bias. Definitions of the behaviours 
assessed can be specific to that individual and differ between parents (Aspland & Gardner, 
2003). Parent-report of child behaviour can be altered by systematic biases such as parental 
mood (Aspland & Gardner, 2003), which can influence perceptions of the child’s behaviour. 
When mothers are experiencing feelings of depression, they can be more likely to perceive 
their children’s behaviour as problematic (Panaccione & Wahler, 1986; Najman et al., 2000). 
Additionally, the use of parental self-report for child behavioural problems could result in 
under-reporting of behaviour. Parental report measures can be prone to desirability bias, which 
suggests that some parents could answer the questions in a way that portrays them or their 
children in a more socially acceptable or desirable way. However, parent reports of behaviour 
are also highly beneficial as parents can observe the child in many contexts and across various 
periods. As discussed in the method section of this thesis, the SDQ is a valid, reliable measure 






clinical measure to measure mental health difficulties, such as the DAWBA in the present 
study, can mitigate the subjective nature of parent-report.  
Another limitation is the potential for other confounding variables that may not have 
been controlled for during analysis. The current study did not control for factors that may be 
present in the child’s postnatal environment. Adverse child, maternal and familial factors 
occurring between birth and the 4.5-year psychological assessment can be considered 
mediators of the relationship between prenatal methadone exposure and mental health 
outcome, which were not the focus of the present study. Confounding factors correlated with 
maternal methadone use that occurred within the pregnancy/birth period were the primary 
focus.   
Lastly, this study is limited by the age group that was assessed. At age 4.5 years old, 
there is a low base rate of psychiatric disorders compared to older children. Further follow-up 
of these children is necessary to assess the trajectory and stability of disorders. As children 
grow older, their cognition and behaviour also grow in complexity (Nygaard et al., 2016). 
Therefore, future research on the mental health outcomes of ME children at older ages and 
across both home and school settings will be important for further understanding of the extent 
and nature of their mental health difficulties.   
4.5  Future Research Directions  
In the current study, mothers who were maintained on methadone during pregnancy 
were found to have markedly higher rates of adverse socio-familial factors that may expose 
children to high-risk contexts throughout childhood. Therefore, this raises further concern 
about the influence and contribution of these factors to the future developmental trajectory of 
these children. As discussed in the limitations, this study did not explore the potential mediating 
factors that may be present in the relationship between methadone exposure in-utero and child 






parent-child interaction, trauma, stress and parenting may help to provide a clearer picture of 
methadone exposure effects. Additionally, it could be beneficial to investigate the protective 
factors that may attenuate the risk of mental health difficulties in ME children and promote 
resilience. Protective factors at the individual, familial and wider community level may be 
associated with a decreased risk of child psychiatric difficulties.  
Future research could also explore teacher-reported externalising and internalising 
behaviour difficulties in ME children. The DAWBA often incorporates teacher-reported 
information about children’s difficulties during the psychological assessment. This 
comprehensively gathers information on the child’s behaviour at home and in the school setting 
(Goodman et al., 2000). The use of both caregiver and teacher report can provide information 
on the extent to which child behavioural and emotional difficulties are pervasive across 
different environmental conditions or whether observed difficulties may be situational or 
confined to a single setting, such as at home or school.  
 4.6  Conclusion 
The present study aimed to investigate the extent of parent-reported behavioural and 
emotional maladjustment in ME and comparison preschool children. The rates of DSM-IV 
externalising and internalising disorders were also examined for both groups. Diagnostic 
comorbidities were also assessed in the ME group. The last aim of the present study was to 
investigate the potential confounding factors during pregnancy/birth that may also contribute 
to the observed outcomes. As hypothesised, ME children had elevated levels of conduct 
problems, hyperactivity/inattention, emotional symptoms and peer problems compared to 
comparison children, as measured on the SDQ. Methadone-exposed children also had lower 
levels of prosocial behaviour. Further analysis of the children who fell within the clinically 
significant range of the SDQ subscales revealed statistically significant differences between 






approached significance (p = .05). Methadone-exposed children were also more likely to be 
diagnosed with an externalising disorder, however, they were not at risk of meeting diagnostic 
criteria for an internalising disorder at 4.5 years old. Further exploration of confounding 
variables correlated with maternal methadone use during pregnancy resulted in attenuation of 
group status significance for ADHD but not for CD/ODD. In-utero methadone exposure was 
the only variable that significantly predicted CD/ODD at 4.5 years old, despite the presence of 
multiple birth/maternal risk factors. Methadone-exposed children were also significantly more 
likely to be diagnosed with co-occurring mental health disorders. However, further follow-up 
of the developmental trajectory of these disorders is needed.  
The findings from the present study highlight the importance of ME children’s prenatal 
environment and the effects of adverse maternal and social risk factors on long-term 
development. Not only are ME children at risk of behavioural and emotional maladjustment 
and developing mental health disorders during the preschool years, but their complex 
environment can exacerbate the risk. The combination of teratogenic exposure as well as 
adverse birth, maternal and social risk factors accentuates the vulnerability of ME children and 
their mothers. The high rates of psychiatric disorders at such an early age combined with high 
levels of comorbidity raise particular concerns for the welfare of these children. Early 
intervention and specialised long-term support for children, mothers and families involved with 
methadone maintenance treatment is necessary and will hopefully result in positive 
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Strengths and Difficulties Questionnaire P
For each item, please mark the box for Not True, Somewhat True or Certainly True.  It would help us if you answered all items as
best you can even if you are not absolutely certain.  Please give your answers on the basis of your child's behaviour over the last
six months.
Your child's name .............................................................................................. Male/Female
Date of birth...........................................................
Considerate of other people's feelings □ □ □
Restless, overactive, cannot stay still for long □ □ □
Often complains of headaches, stomach-aches or sickness □ □ □
Shares readily with other children, for example toys, treats, pencils □ □ □
Often loses temper □ □ □
Rather solitary, prefers to play alone □ □ □
Generally well behaved, usually does what adults request □ □ □
Many worries or often seems worried □ □ □
Helpful if someone is hurt, upset or feeling ill □ □ □
Constantly fidgeting or squirming □ □ □
Has at least one good friend □ □ □
Often fights with other children or bullies them □ □ □
Often unhappy, depressed or tearful □ □ □
Generally liked by other children □ □ □
Easily distracted, concentration wanders □ □ □
Nervous or clingy in new situations, easily loses confidence □ □ □
Kind to younger children □ □ □
Often lies or cheats □ □ □
Picked on or bullied by other children □ □ □
Often volunteers to help others (parents, teachers, other children) □ □ □
Thinks things out before acting □ □ □
Steals from home, school or elsewhere □ □ □
Gets along better with adults than with other children □ □ □
Many fears, easily scared □ □ □
Good attention span, sees chores or homework through to the end □ □ □
Do you have any other comments or concerns?






































APPENDIX B: DAWBA INTERVIEW AT 4.5 YEAR ASSESSMENT 
 
CANTERBURY CHILD DEVELOPMENT STUDY 
MATERNAL INTERVIEW SUPPLEMENT 
 






CODE    
 
 
INTERVIEWER    
 
 
                               DD  MM         YY 







CHILDS DEVELOPMENT AND WELL BEING 
SDQ Scale Card 
 
SDQ Emotion Score 0 1 2 3 4 5 6 7 8 9 10  
SDQ Hyperactivity Score 0 1 2 3 4 5 6 7 8 9 10  
SDQ Conduct Score 0 1 2 3 4 5 6 7 8 9 10  
SDQ Peer Score 0 1 2 3 4 5 6 7 8 9 10  
SDQ Prosocial Score 0 1 2 3 4 5 6 7 8 9 10  
Peer minus Prosocial    (positive score reflects peer score > prosocial score) 
    (negative score reflects peer score < prosocial score) 



















SECTION 1.2 - Friendships 
 












   0 1 2 
 
 
Fr 2 What is [Name] like at keeping the friends 













   0 1 2 
 
 
Fr 3 At present, how many friends does 
s/he have that s/he fairly often spends 
time with, for example chatting, or 
doing things together, or going out as 





   0 1 2 3 4 
   
 
    
   Next section Fr 4    
 
SECTION 1.3 – Separation Anxiety (worries and concerns that children might 
have) 
 
Most children are particularly attached to a few key adults, looking to them for security 
and comfort, and turning to them when upset or hurt. 
 
1.3.1 Is [Name] specially attached to the following adults? 
No or Not 
Applicable Yes 
a) Mother (biological or adoptive) 0 1 
b) Father (biological or adoptive) 0 1 
c) Another mother figure (stepmother, foster mother, father’s partner) 0 1 






1.3.1 Is [Name] specially attached to the following adults? 
No or Not 
Applicable Yes 
e) One or more grandparents 0 1 
f) One or more other adult relatives (e.g. aunt, uncle, grown-up brother or sister) 0 1 
g) Childminder, nanny, au pair 0 1 
h) One or more teachers 0 1 
i) One or more other adult non-relatives (e.g. a family friend or neighbour) 0 1 
j) [  ] Not specially attached to any adult 0 1 
 
If 1.3.1j was ticked, ask 1.3.1k , 1.3.1l and 1.3.1m; otherwise continue with 1.3.2 
 
 Is [(Child) specially attached to the following 





k) One or more brothers, sisters or other young relatives 0 1 
l) One or more friends 0 1 






If 1.3.1m is ticked, then skip to section 2 (Fears of specific things or situations). 
Otherwise continue: 
 
1.3.2 You’ve just told me who [Name] is specially attached to: If you want, you can 
list all from 1.3.1 that were answered ‘Yes’: From now on I am going to refer to these 
people as his/her ‘attachment figures’ 
 
What I’d like to know next is how much [Name] worries about being separated from 
his/her attachment figures. Most children have some worries of this sort, but I’d like to 
know how [Name] compares with other children of his/her age. I am interested in how s/he 
is usually- not on the occasional ‘off day’. 
 
  No Yes 
 Overall, in the last 4 weeks, has s/he been particularly 







If 1.3.2 = Yes or if SDQ emotion score is ≥3 then continue. If neither skip to section 2 











1.3.3 Over the last 4 weeks, and compared with other children of the same age…… 













has s/he worried either about something 
unpleasant happening to his/her attachment 
figures, or about losing them? 
 
0 1 2 
b) 
has s/he worried unrealistically that s/he 
might be taken away from his/her 
attachment figures e.g. by being kidnapped, 
taken to hospital or killed? 
 
0 1 2 
c)  
has s/he not wanted to go to school in case 
something nasty happened to his/her 
attachment figures while s/he was away at 
school? (Do not include reluctance to go to 
school for other reasons e.g. fear of 
bullying or exams) 
0 1 2 
d)     has s/he worried about sleeping alone? 0 1 2 
e)  
has s/he come out of his/her bedroom at 
night to check on, or to sleep near, his/her 
attachment figures? 
 
0 1 2 
f) has s/he worried about sleeping in a strange place? 0 1 2 
g) 
(Only ask if aged under 11) 
 
has s/he been afraid of being alone in a 
room at home without his/her attachment 
figures even if they are close by? 
0 1 2 
h) 
(Only ask if aged under 11) 
 
has s/he been afraid of being alone at 
home if his/her attachment figures pop out 
for a moment? 
 
0 1 2 
i) 
has s/he repeated nightmares or bad 
dreams about being separated from his/her 
attachment figure? 
 



















has s/he had headaches, stomach aches or 
felt sick when s/he had to leave his/her 
attachment figures or when s/he knew it 
was about to happen? 
 
0 1 2 
k) 
has being apart from his/her attachment 
figures, or the thought of being apart from 
them led to worry, crying, tantrums, 
clinginess or misery? 
0 1 2 
 
 
If any of the items in 1.3.3 have been answered “A lot more than others” then continue 




1.3.4 Have [Name’s] worries about separation been 
there for at least 4 weeks? 
No Yes 
 0 1 
 
1.3.5 How old was s/he when his/her worries about 

































1.3.7 Have these worries interfered with…… 
a) How well s/he gets on with you and the rest of the family? 0 1 2 3 
b) Making and keeping friends? 0 1 2 3 
c) learning or class work? 0 1 2 3 





Have these worries put a burden on you 
















 0 1 2 3 
 
 
SECTION 2 - Fears of specific things or situations 
 
This section of the interview is about some things or situations that children are often 
scared of, even though they aren’t really a danger to them. I’d like to know what [Name] is 
afraid of. I am interested in how s/he is usually – not on the occasional ‘off day’. Not all 
fears are covered in this section – some are covered in other sections e.g. fears of social 
situations, dirt, separation, crowds. 
 







a) Animals: Dogs, spiders, bees and wasps, mice and rats, snakes, or any other animal, bird or insect 0 1 2 
b) Some aspect of the natural environment, e.g. storms, thunder, heights, water 0 1 2 
c) The dark 0 1 2 
d) Loud noises, e.g. fire alarms, fireworks 0 1 2 
e) 
Blood – injection – injury: Set off by the sight of blood 
or injury, or by an injection, or by other medical 
procedures 
0 1 2 
f) Dentists or doctors 0 1 2 
g) Vomiting, choking or getting particular diseases, e.g. cancer or AIDS 0 1 2 
h) Using particular types of transport, e.g. cars, buses, boats, planes, ordinary trains, underground trains, bridges 0 1 2 
i) Small enclosed spaces, e.g. lifts, tunnels 0 1 2 
j) Using the toilet, e.g. at school or in someone else’s house 0 1 2 
k) 
Specific types of people, e.g. clowns, people with 
beards, with crash-helmets, in fancy dress, dressed as 
Santa Claus 
0 1 2 
l) Imaginary or supernatural beings, e.g. monsters, ghosts, aliens, witches 0 1 2 
m) 











If any of the items in 2.1 have been answered ‘a lot’ then continue with 2.2. Otherwise 
go to Section 3. 
 
2.2 Are any of these fears a real nuisance to 
him/her, to you, or to anyone else? No Perhaps Definitely  
0 1 2 
 
If 2.2 = “Definitely” or if SDQ emotion score is ≥3 then continue. If neither, then skip 
to Section 3. 
 
2.3 How long has this fear or the most severe of 









 0 1 2 
 
2.4 When [Name] comes up against the things 
s/he is afraid of, or when s/he thinks s/he is 
about to come up against them, does s/he 
become anxious or upset? 
No 
A 
little A lot 
 0 1 2 
     
  2.7 2.5 
 
2.5 Does s/he become anxious or upset every 
time, or almost every time, s/he comes up 
against the things s/he is afraid of? 
No Yes 
 0 1 
 
 
2.6 How often do his/her fears result in his/her 













 N.B. If [Name] is afraid of something that 
is only there for part of the year (e.g. wasps), 
this question is about that particular season. 
0 1 2 3 
 
 
2.7 Do [Name’s] fears lead to him/her avoiding 
the things s/he is afraid of? No 
A 
little A lot 
 0 1 2 
     
  2.9 2.8 
 
 
2.8 Does this avoidance interfere with his/her 
daily life? No 
A 













Do you think that his/her fears are over the 
top or unreasonable? 
No Perhaps Definitely 
0 1 2 
     
2.10 And what about him/her? Does s/he think 
that his/her fears are over the top or 
unreasonable? 






Have [Name’s] fears put a burden on 











 0 1 2 3 
SECTION 3 – Fear of social situations 
 
I am interested in whether [Name] is particularly afraid of social situations. This is 
compared with other children of his/her age, and is not counting the occasional ‘off day’ or 
ordinary shyness. 
 
3.1 Overall, does [Name’s] particularly fear or avoid 
social situations that involve a lot of people, meeting 
new people, or doing things in front of people? 
No Yes 
 0 1 
 
 
If 3.1 = “Yes” or if SDQ emotion score is ≥3, then continue. If neither, then skip to 
section 4. 
 
3.2 Has [Name] been particularly afraid of any of the 





a) Meeting new people? 0 1 2 
b) Meeting a lot of people, such as at a party? 0 1 2 
c) Eating in front of others? 0 1 2 
d) Speaking in class? 0 1 2 
e) Reading out loud in front of others? 0 1 2 







If none of the items in 3.2 have been answered “A lot”, skip to section 4; otherwise 
continue.  
 
3.3  Most children are attached to a few key adults, feeling more secure when they are 
around. Some children are only afraid of social situations if they don’t have one of these 
key adults around. 
 




Which is true for [Name]? 
 
Mostly fine in social 
situations as long as key 
adults are around 
Social fears are 
marked even when key 









Is [Name] just afraid with adults, or is s/he 
also afraid in situations that involve a lot of 













 0 1 2 
 
 
3.5 Outside of these social situations is {name} able to 
get on well enough with the adults and children s/he 
knows best? 
No Yes 
 0 1 
 
 
3.6 Do you think his/her dislike of social 
situations is because s/he is afraid s/he 
will act in a way that will be embarrassing 
or show him/her up? 
No Perhaps Definitely 
 
0 1 2 
 
(Only ask if 3.2d=’A lot’ or 3.2e = ‘A lot’ or 3.2f = ‘A lot’) 
 
3.7 Is his/her dislike of social situations 
related to specific problems with speech, 
reading or writing? 
No Perhaps Definitely 
 0 1 2 
 
 
3.8 How long has his/her fear of social 

















3.9 How old was s/he when this fear of social 




3.10 When [Name’s] is in one of the social 
situations s/he fears, or when s/he thinks s/he is 
about come up against one of these situations, 
does s/he become anxious or upset 
No 
A 
little A lot 
 0 1 2 
    
 3.12 3.11 
 
 
3.11 How often does his/her fear of social 
situations result in him/her becoming 












 0 1 2 3 
 
3.12 Does his/her fear lead to [Name] avoiding 
social situations No 
A 
little A lot 
 0 1 2 
    
 3.14 3.13 
 
 
3.13 Does this avoidance interfere with 
his/her daily life? 
No A little A lot 






Does s/he think that this fear of social 
situations is over the top or 
unreasonable 
No Perhaps Definitely 
0 1 2 
     
3.15 Is s/he upset about having this fear? 





Has [Name’s] fear of social situations 





















SECTION 4 - Panic Attacks and Agoraphobia 
 
Many children have times when they get very anxious or worked up about silly little 
things, but some children get severe panics that come out of the blue- they just don’t seem 
to have any trigger at all. 
 
4.1 In the last 4 weeks, has [Name] had a panic attack 
when s/he suddenly became very panicky for no 






4.2 Over the last 4 weeks, has [Name] been very afraid 




a) Crowds 0 1 
b) Public Places 0 1 
c) Travelling alone (If s/he ever does so) 0 1 
d) Being far from home 0 1 
If any of the items in 4.2 have been answered “Yes”’ then continue with 4.3. Otherwise 
skip to section 5. 
 
 
4.3 Do you think this fear or avoidance of (situation) is 
because s/he is afraid that if s/he had a panic attack, 
or something like that, s/he would find it difficult or 
embarrassing to get away, or wouldn’t be able to get 






SECTION 5 - Generalized Anxiety 
 












  Section 6 Continue 
 
 
Some children worry about just a few things, sometimes related to specific fears, 






their lives. They may have specific fears, obsessions or separation anxieties, but they also 





Is [Name] a worrier in general? 
No, s/he just 

















5.2 Over the last 6 months, has [Name] 
worried so much about so many things 
that it has really upset him/her or 
interfered with his/her life? 
No Perhaps Definitely 
 
0 1 2 
 
If 5.2 = “Perhaps” or 5.2 = “Definitely” or SDQ emotion score is ≥3, then continue. If 






5.3 Over the last 6 months, and by comparison with 

















a) Past behaviour: Did I do that wrong? Have I upset someone? Have they forgiven me? 0 1 2 
b) School work, homework or examinations 0 1 2 
c) Disasters: Burglaries, muggings, fires, bombs etc. 0 1 2 
d) His/Her own health 0 1 2 
e) Bad things happening to others: family, friends, pets, the world (e.g. wars). 0 1 2 
f) The future: e.g. changing school, moving house, getting a job, getting a boy/girlfriend 0 1 2 






h) Death and dying 0 1 2 
i) Being bullied or teased 0 1 2 
j) His/Her appearance or weight 0 1 2 
k) 
Other specific worry 
(Describe)………………………………………… 
……………………………………………………. 
0 1 2 
 
If 2 or more of these worries are scored ‘A lot more than others’ then continue, else skip 
to Section 6. 
 
5.4 Over the last 6 months has s/he worried 
excessively on more days than not? 
No Yes 
 0 1 
 
 
5.5 Does s/he find it difficult to control the worry? No Yes 
 0 1 
 





If any of the following questions are answered “yes”, ask “Has this been true for more 
days than not in the last 6 months?” and record answer in the second column. 
 
5.6    
 
In general 
 More days 
than not in the 
last 6 months 
  No Yes  No Yes 
a) 
Does worrying lead to him/her 
feeling restless, keyed up, on edge, 
or unable to relax? 
0 1  0 1 
b) 
Does worrying lead to him/her 
feeling tired or worn out more 
easily? 
0 1  0 1 
c) 
Does worrying lead to difficulties 
in concentrating or his/her mind 
going blank? 
0 1  0 1 
d) Does worrying lead to irritability? 0 1  0 1 
e) Does worrying lead to muscle tension? 0 1 







Does worrying interfere with 
his/her sleep, e.g. difficulty in 
falling or staying asleep, or restless, 
unsatisfying sleep? 





How upset or distressed is [Name] as a 


























a) how well s/he gets on with you and the rest of the family? 0 1 2 3 
b) making and keeping friends? 0 1 2 3 
c) learning or class work? 0 1 2 3 






Have these worries put a burden on you or 











 0 1 2 3 
 
 
SECTION 6 - Depression 
 
This section of the interview is about [Name’s] mood. 
 
6.1 In the last 4 weeks, have there been 
times when [Name] has been very sad, 
miserable, unhappy or tearful in a way 
that has been out of character for 
him/her? 
No Yes 




 6.7 6.2 
 Over the last 4 weeks has there been a 
period when s/he has been really 
miserable nearly every day 
No Yes 







6.3 During the time when s/he has been miserable, 
has s/he been really miserable for most of the 
day? (i.e. for more hours than not) 
No Yes 





When s/he has been miserable, could 









 0 1 2 
 
6.5 Over the last 4 weeks, the period of being 
really miserable has lasted: 
Less than 2 
weeks 
2 weeks or 
more 
 0 1 
 
6.7(Sic) In the last 4 weeks, have there been 
times when [Name] has been grumpy 
or irritable in a way that has been out 
of character for him/her? 
No Yes 




 6.13 6.8 
 
6.8 Over the last 4 weeks, has there been a period 
when s/he has been really grumpy or irritable 
nearly every day? 
No Yes 
 0 1 
 
6.9 During the time when s/he has been miserable, 
has s/he been grumpy or irritable for most of the 
day? (i.e. for more hours than not) 
No Yes 




6.10 Has the irritability been improved by 
particular activities, by friends coming 








 0 1 2 
 
6.11 Over the last 4 weeks, the period of being 
really irritable has lasted: 
Less than 
2 weeks 
2 weeks or 
more 




In the last 4 weeks, have there been 
times when [Name] has lost interest in 















6.14 Over the last 4 weeks, has there been a period 
when this lack of interest has been present 
nearly every day? 
No Yes 
 0 1 
 
6.15 During these days when s/he has lost interest 
in things, has/he been like this for most of the 
day? (i.e. for more hours than not) 
No Yes 
 0 1 
 




2 weeks or 
more 
 0 1 
 
Ask 6.17 if 6.1 and 6.2 and 6.3 = “Yes” OR if 6.7 and  6.8. and 6.9 = “Yes 
 
6.17 Has this loss of interest been present during 
the same period when s/he has been really 
miserable or irritable for most of the time 
No Yes 
 0 1 
 
 
Ask 6.18 if  6.1 and 6.2 and 6.3 = “Yes” OR 6.7 and 6.8. and 6.9 = “Yes  











a) Did s/he lack energy and seem tired all the time? 0 1 
b) Was s/he eating much more or much less than normal? 0 1 
c) Did s/he either lose or gain a lot of weight? 0 1 
d) Did s/he find it hard to get to sleep or to stay asleep? 0 1 
e) Did s/he sleep too much? 0 1 
f) Was s/he agitated or restless for much of the time? 0 1 








h) Did s/he find it unusually hard to concentrate or think things out? 0 1 
i) Did s/he think about death a lot? 0 1 
j) Did s/he think about harming himself/herself or killing himself/herself? 0 1 
k) Did s/he try to harm himself/herself or kill himself/herself 0 1 
l) Over the whole of his/her lifetime, has s/he ever tried to harm himself/herself or kill himself/herself 0 1 
 
 
6.19 How much has [Name’s] sadness, 
irritability or loss of interest upset or 
distressed him/her 
Not at 






 0 1 2 3 
 
 
6.20 Has his/her sadness, irritability or 










a) how well s/he gets on with you and the rest of the family? 0 1 2 3 
b) making and keeping friends? 0 1 2 3 
c) learning or class work? 0 1 2 3 
d) playing, hobbies, sports or other leisure activities? 0 1 2 3 
 
6.21 Has his/her sadness, irritability or 
loss of interest put a burden on you 
















6.22 Over the last 4 weeks, has s/he talked about 
deliberately harming or hurting himself/herself? 
No Yes 








6.23 Over the last 4 weeks, has s/he tried to harm 
himself/herself? 
No Yes 
 0 1 
 
6.24 Over the whole of his/her lifetime, has s/he ever tried 








SECTION 7- Attention and Activity 
 
 
This section of the interview is about [Name’s] level of activity and concentration over the 
last 6 months. Nearly all children are overactive or lose concentration at times, but what I 
would like to know is how [Name] compares with other children of his/her own age. I am 
interested in how s/he is usually – not on the occasional ‘off day’. 
 
7.1 Allowing for his/her age, do you think that [Name] 
definitely has some difficulties with overactivity or poor 
concentration? 
No Yes 
  0 1 
 





I would now like to go through some more detailed questions about how [Name] has 
usually been over the last 6 months. I will start with questions about how active s/he has 
been. 
  
7.2 Over the last 6 months, and by comparison 











a) Does s/he often fidget? 0 1 2 
b) Is it hard for him/her to stay sitting down for long? 0 1 2 
c) Does s/he run or climb about when s/he shouldn’t? 0 1 2 
d) 
Does s/he find it hard to play or take part in 
other leisure activities without making a lot of 
noise? 







If s/he is rushing about, does s/he find it 
hard to calm down when someone asks 
him/her to? 
0 1 2 
 
The next few questions are about impulsiveness 
 
7.3 Over the last 6 months, and by comparison 











a) Does s/he often blurt out an answer before s/he heard the question properly? 0 1 2 
b) Is it hard for him/her to wait his/her turn? 0 1 2 
c) Does s/he often butt in on other people’s conversations or games? 0 1 2 
d) Does s/he often go on talking if s/he has been asked to stop, or if no one is listening? 0 1 2 
 
The next set of questions are about attention 
 
7.4 Over the last 6 months, and by comparison 












Does s/he often make careless mistakes or fail 
to pay attention to what s/he is supposed to be 
doing? 
0 1 2 
b) Does s/he often lose interest in what s/he is doing? 0 1 2 
c) Does s/he often not listen to what people are saying to him/her? 0 1 2 
d) Does s/he often not finish a job properly? 0 1 2 
e) Is it often hard for him/her to get himself/herself organized to do something? 0 1 2 
f) Does s/he often try to get out of things s/he would have to think about, such as homework? 0 1 2 
g) Does s/he often lose things s/he needs for school or games? 0 1 2 
h) Is s/he easily distracted? 0 1 2 
i) Is s/he often forgetful? 0 1 2 
 





















M2J5) Is his or her level of activity or his or her lack of attention interfering with his or 





M2J6) Have you tried to do anything about his or her overactivity, lack of attention or 
impulsiveness? If so, please describe what you’ve tried to do, any help that you have had, 







7.5 Have [Name’s] teachers complained 















a) fidgetiness, restlessness or overactivity? 0 1 2 
b) poor concentration or being easily distracted? 0 1 2 
c) 
Acting without thinking about what s/he 
is doing, frequently butting in, or not 
waiting his/her turn? 
0 1 2 
 
If two or more of the items in 7.2, 7.3 or 7.4 have been answered “A lot more than 
others,” then continue to 7.6. If not, skip to section 8. 
 
7.6 Have [Name’s} difficulties with activity or 
concentration been there for at least 6 months? No Yes 
  0 1 
 






 How old was s/he when his/her difficulties with 
activity or concentration began? 
(if since birth, enter 0) 
 
 
7.8 How much have [Name’s] 
difficulties with activity or 












 0 1 2 3 
 
 
7.9 Have [Name’s] difficulties with 












a) how well s/he gets on with you and the rest of the family? 0 1 2 3 
b) making and keeping friends? 0 1 2 3 
c) learning or class work? 0 1 2 3 
d) playing, hobbies, sports or other leisure activities? 0 1 2 3 
 
7.10 Have these difficulties with 
activity or concentration put a 
















SECTION 8-Awkward and Troublesome Behaviour 
 
This next section of the interview is about behaviour. Nearly all children are awkward and 
difficult at times – not doing what they are told, being irritable or annoying, having temper 
outbursts, and so on. What I would like to know is how [Name] compares with other 
children of the same age. I am interested in how s/he is usually, and not just on occasional 
‘off days’. 
 
8.1 Thinking about the last 6 months, how 
does [Name’s] behaviour compare with 




















If 8.1 = “More awkward or troublesome than average”, or if SDQ conduct problems 
score is ≥4, then continue. If neither, then skip to section 9 
 
Some children are awkward or annoying with just one person – perhaps with yourself or 
just one brother or sister. Other children are troublesome with a range of adults or children. 
The following questions are about how [Name] is in general, and not just with one person. 
 
8.2 Over the last 6 months, and as compared 











a) had temper outbursts? 0 1 2 
b) argued with grown-ups? 0 1 2 
c) taken no notice of rules, or refused to do as s/he is told? 0 1 2 
d) seemed to do things to annoy other people on purpose? 0 1 2 
e) blamed others for his/her own mistakes or bad behaviour? 0 1 2 
f) been touchy or easily annoyed? 0 1 2 
g) been angry and resentful? 0 1 2 
h) been spiteful? 0 1 2 
i) tried to get his/her own back on people? 0 1 2 
 
If any of the items in 8.2 have been answered “A lot more than others”, then continue 
with 8.3. If not, skip to 8.8. 
 
 
8.3 Have [Name’s] teachers complained over the 
last 6 months of problems with this kind of 
awkward behaviour or disruptiveness in class? No A little A lot 
  0 1 2 
 
 
8.4 Has [Name’s} awkward behaviour been there for at 
least 6 months? No Yes 








8.5 How old was s/he when this sort of awkward 
behaviour began? (if since birth, enter 0) 
 years old 
 
 
8.6 Has [Name’s] awkward behaviour 
interfered with….. Not at 






a) how well s/he gets on with you and the rest of the family? 0 1 2 3 
b) making and keeping friends? 0 1 2 3 
c) learning or class work? 0 1 2 3 
d) playing, hobbies, sports or other leisure activities? 0 1 2 3 
 
 
8.7 Has his/her awkward behaviour put a 
burden on you or the family as a 
whole? 
Not at 






 0 1 2 3 
 
 
Continue with 8.8.  
 
Behaviour that sometimes gets children into trouble. 
 
I’m now going to ask about behaviour that sometimes gets children into trouble, including 
dangerous, aggressive or antisocial behaviour. Please answer according to how s/he has 







If any of the following questions are answered “Definitely” ask “Has this been going 
on for the last 6 months?” and record answer in the second column. 
 
8.8 As far as you know, over 
the last 12 months… Over the last 12 months  
Last 6 
months 
  No Perhaps Definitely  No Yes 
a) 
has s/he often told lies in 
order to get things or 
favours from others, or to 
get out of having to do 
things s/he is supposed to 
do? 








8.8 As far as you know, over 




has s/he often started 
fights? (Other than with 
brothers and sisters) 
0 1 2  0 1 
c) has s/he often bullied or threatened people? 0 1 2 
 0 1 
d) 
has s/he often stayed out 
after dark much later than 
s/he was supposed to? 
0 1 2  0 1 
e) 
has s/he stolen from the 
house, or from other 
people’s houses, or from 
shops or school? (This 
doesn’t include very 
minor thefts e.g. stealing 
his/her brother’s pencil or 
food from the fridge) 




has s/he run away from 
home more than once, or 
ever stayed away all night 
without your permission? 




has s/he often played 
truant (bunked off) from 
school? 
0 1 2  0 1 
 
 
Only continue with 8.9 if any of the items in 8.2 have been answered “A lot more than 
others”,  or any of the items  in 8.8 have been answered “Definitely” otherwise skip to 
section 9 
 
May I now ask you about a list of less common but potentially more serious behaviours? I 






If any of the following questions are answered “Yes” then ask “Has this happened in the 
last 6 months?” and record answer in second column 
 
8.9 As far as you know, have any of the 
following happened even once in the 
last 12 months? 
Over the last 
12 months  Last 6 months 






8.9 As far as you know, have any of the 
following happened even once in the 
last 12 months? 
Over the last 
12 months  Last 6 months 
a) 
Has s/he used a weapon or anything 
that could seriously hurt someone? (e.g. 





Has s/he really hurt someone or been 
physically cruel to them (e.g. has tied 




c) Has s/he been really cruel on purpose to animals and birds 0 1 
 0 1 
d) 
Has s/he deliberately started a fire? 
(This is only if s/he intended to cause 
severe damage. This question is not 
about lighting campfires, or burning 





Has s/he deliberately destroyed 
someone else’s property? (This question 
is not about fire setting or very minor 
acts e.g. destroying sister’s drawing. It 
does include behaviour such as 






Has s/he been involved in stealing on 
the streets, e.g. snatching a handbag or 
mugging? 
0 1  0 1 
g) Has s/he broken into a house, any other building or a car? 0 1 




Have [Name’s] teachers complained of troublesome 
behaviour over the last 6 months? No Yes 




Has his/her troublesome behaviour been present for at 
least 6 months? No Yes 
  
 0 1 
  
  
8.10 Has [Name] ever been in trouble with the police? 











If any items in 8.8 have been ticked “Definitely” or items in 8.9 answered “Yes”, then 
continue. Otherwise skip to section 9 
 
8.11 Has [Name’s] troublesome behaviour interfered with…. 
  Not at 






a) how well s/he gets on with you and the rest of the family? 0 1 2 3 
b) making and keeping friends? 0 1 2 3 
c) learning or class work? 0 1 2 3 
d) playing, hobbies, sports or other leisure activities? 0 1 2 3 
 
8.12 Has his/her troublesome behaviour 
put a burden on you or the family as 
a whole? 











SECTION 9- Strengths 
 
I have been asking you a lot of questions about difficulties and problems. I now want to 
ask you about (Child’s) good points or strengths.  
 
9.1 
Do the following descriptions apply to him/her? No A little A lot 
a) Generous 0 1 2 
b) Lively 0 1 2 
c) Keen to learn 0 1 2 
d) Affectionate 0 1 2 
e) Reliable and responsible 0 1 2 
f) Easy going 0 1 2 







Do the following descriptions apply to him/her? No A little A lot 
h) Interested in many things 0 1 2 
i) Caring, kind hearted 0 1 2 
j) Bounces back quickly after setbacks 0 1 2 
k) Grateful, appreciative of what s/he gets 0 1 2 
l) Independent 0 1 2 
 
 
9.2 What are the things s/he does that really please 
you? No A little A lot 
a) Helps around the home 0 1 2 
b) Gets on well with the rest of the family 0 1 2 
c) Does homework without needing to be reminded 0 1 2 
d) Creative activities: art, acting, music, making     things 0 1 2 
e)      Likes to be involved in family activities 0 1 2 
f) Takes care of his/her appearance 0 1 2 
g) Good at school work 0 1 2 
h) Polite 0 1 2 
i) Good at sport 0 1 2 
j) Keeps his/her bedroom tidy 0 1 2 
k) Good with friends 0 1 2 
l) Well behaved 0 1 2 
 












APPENDIX C: CONSENT FORMS FOR THE 4.5-YEAR FOLLOW-UP 
 
 
Canterbury Child Development 
Research Group 
Department of Psychology  
College of Science  
November 2007  
                         
 









• I have been invited to participate with my child in a study that is comparing the development 
of children who were and were not born to mothers on methadone maintenance during their 
pregnancy. I have read and understood the Information sheet dated November, 2007.  
 
 
• I have had enough time to consider whether we will take part in the study, and to discuss my 
decision with the researcher or a person of my choice.  
 
 
• I know who to contact if I have any questions about the study.  
 
 
• I understand that our participation in this research is confidential and that no material which 
could identify me will be used in any study reports, or made available to anyone else without 
my approval in writing.  
 
 
• I understand my child will be videotaped during the procedure and that this information will 
only be used for further observation by the named investigators and the material will be 
secured and kept strictly confidential.  
 
 
• I also understand that my child and I can withdraw from the study at any time. 
 
 








• I agree to members of the research team having access to medical information about 
 my child for cross checking the number and dates of any major or minor illnesses that 
 I have recorded on the study forms. 
 
• I wish to receive a summary of the results of this study.  
 
I consent to take part in this study.  
 
Parent/s Name: ______________________________________  
 
Signature of Parent/s: _________________________________ Date: ______________________  
 
I consent to my child taking part in this study.  
 
Child’s name_______________________________  
Parent/s Name: _______________________________  
 
Signature of Parent/s: _________________________________ Date: ______________________  
 
In my opinion, consent was given freely and the participant understands what is involved in this 
study.  
 
Researcher’s Name:___________________________________  
 
Signature of Researcher: ______________________________ Date: ______________________  
 
YES/NO 
YES/NO 
